IP/QB.10_NNP m.91.b_NN ._.
No_DT ._.
44_CD ._.
(_( NEW_JJ SERIES_NNP ._. )_)
SCIENTIFIC_NNP MEMOIRS_NNP BY_NNP OFFICERS_NNP OF_IN THE_NNP MEDICAL_NNP AND_NNP SANITARY_NNP DEPARTMENTS_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP The_DT Preparation_NNP of_IN a_DT Safe_NNP and_CC Efficient_NNP Antirabic_NNP Vaccine_NNP BY_NNP LIEUT.-COLONEL_NNP SIR_NNP D._NNP SEMPLE_NNP ,_, KT._NNP ,_, M.D._NNP ,_, D.P.H._NNP ,_, R.A.M.C_NNP ._.
(_( Retired_NNP )_) Director_NNP ,_, Central_NNP Research_NNP Institute_NNP ,_, Kasauli_NNP ISSUED_NNP UNDER_NNP THE_NNP AUTHORITY_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP BY_NNP THE_NNP SANITARY_NNP COMMISSIONER_NNP WITH_NNP THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP ,_, SIMLA_NNP [_NNP NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75058084.tif_CD ]_NNS CALCUTTA_NNP SUPERINTENDENT_NNP GOVERNMENT_NNP PRINTING_NNP ,_, INDIA_NNP 1911_CD Price_NNP annas_VBD 8_CD or_CC 9d_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75058090.tif_CD ]_JJ 3943124_CD X_NNP (_( NEW_NNP SERIES_NNP ._. )_)
No_DT ._.
44_CD SCIENTIFIC_NNP MEMOIRS_NNP BY_NNP OFFICERS_NNP OF_IN THE_NNP MEDICAL_NNP AND_NNP SANITARY_NNP DEPARTMENTS_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP The_DT Preparation_NNP of_IN a_DT Safe_NNP and_CC Efficient_NNP Antirabic_NNP Vaccine_NNP BY_NNP LIEUT.-COLONEL_NNP SIR_NNP D._NNP SEMPLE_NNP ,_, KT._NNP ,_, M.D._NNP ,_, D.P.H._NNP ,_, R.A.M.C_NNP ._.
(_( Retired_NNP )_) Director_NNP ,_, Central_NNP Research_NNP Institute_NNP ,_, Kasauli_NNP ISSUED_NNP UNDER_NNP THE_NNP AUTHORITY_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP BY_NNP THE_NNP SANITARY_NNP COMMISSIONER_NNP WITH_NNP THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP ,_, SIMLA_NNP [_NNP NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75058096.tif_CD ]_NNS CALCUTTA_NNP SUPERINTENDENT_NNP GOVERNMENT_NNP PRINTING_NNP ,_, INDIA_NNP 1911_CD [_NNP NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75058096.tif_CD ]_JJ Agents_NNS for_IN the_DT Sale_NNP of_IN Books_NNP published_VBN by_IN the_DT Superintendent_NNP of_IN Government_NNP Printing_NNP ,_, India_NNP ,_, Calcutta_NNP ._.
IN_NNP ENGLAND_NNP ._.
Mr._NNP E._NNP A._NNP ARNOLD_NNP ,_, 41_CD and_CC 43_CD ,_, Maddox_NNP Street_NNP ,_, Bond_NNP Street_NNP ,_, London_NNP ,_, W._NNP Messrs._NNP CONSTABLE_NNP &_CC Co._NNP 10_CD ,_, Orange_NNP Street_NNP ,_, Leicester_NNP Square_NNP ,_, W.C._NNP Messrs._NNP KEGAN_NNP PAUL_NNP ,_, TRENCH_NNP ,_, TRÜBNER_NNP &_CC Co._NNP ,_, 43_CD ,_, Gerrard_NNP Street_NNP ,_, Soho_NNP ,_, London_NNP ,_, W._NNP Mr._NNP BERNARD_NNP QUARITCH_NNP ,_, 11_CD ,_, Grafton_NNP Street_NNP ,_, New_NNP Bond_NNP Street_NNP ,_, W._NNP Messrs._NNP P._NNP S._NNP KING_NNP &_CC SON_NNP ,_, 2_CD and_CC 4_CD ,_, Great_NNP Smith_NNP Street_NNP ,_, Westminster_NNP ._.
Messrs._NNP H._NNP S._NNP KING_NNP &_CC CO._NNP ,_, 65_CD ,_, Cornhill_NNP ,_, and_CC 9_CD ,_, Pall_NNP Mall_NNP ,_, London_NNP ._.
Messrs._NNP GRINDLAY_NNP &_CC Co._NNP ,_, 54_CD ,_, Parliament_NNP Street_NNP ,_, London_NNP ,_, S.W_NNP ._.
Mr._NNP T._NNP FISHER_NNP UNWIN_NNP ,_, 1_CD ,_, Adelphi_NNP Terrace_NNP ,_, London_NNP ,_, W.C._NNP Messrs._NNP W._NNP THACKER_NNP &_CC Co._NNP ,_, 2_CD ,_, Creed_NNP Lane_NNP ,_, London_NNP ,_, E.C_NNP ._.
Mr._NNP B._NNP H._NNP BLACKWELL_NNP ,_, 50_CD and_CC 51_CD ,_, Broad_NNP Street_NNP ,_, Oxford_NNP ._.
Messrs._NNP DEIGHTON_NNP BELL_NNP &_CC CO._NNP ,_, Cambridge_NNP ._.
Messrs._NNP LUZAC_NNP &_CC Co._NNP ,_, 46_CD ,_, Great_NNP Russell_NNP Street_NNP ,_, London_NNP ,_, W.C._NNP ON_NNP THE_NNP CONTINENT_NNP ._.
Mr._NNP OTTO_NNP HARRASSOWITZ_NNP ,_, Mr._NNP KARL_NNP HIERSEMANN_NNP ,_, Leipzig_NNP ._.
Messrs._NNS R._NNP FRIEDLÄNDER_NNP &_CC SOHN_NNP ,_, Berlin_NNP ,_, W.N._NNP ,_, Carlstrasse_NNP ,_, 11_CD ._.
Mr._NNP ERNEST_NNP LEROUX_NNP ,_, 28_CD ,_, Rue_NNP Bonaparte_NNP ,_, Paris_NNP ._.
Mr._NNP MARTINUS_NNP NIJHOFF_NNP The_DT Hague_NNP ,_, Holland_NNP ._.
IN_NNP INDIA_NNP ._.
Messrs._NN THACKER_NNP ,_, SPINK_NNP &_CC CO._NNP ,_, Calcutta_NNP and_CC Simla_NNP ._.
Messrs._NNP NEWMAN_NNP &_CC Co._NNP ,_, Calcutta_NNP ._.
Messrs._NNS R._NNP CAMBRAY_NNP &_CC Co._NNP ,_, Calcutta_NNP ._.
Messrs._NNP S._NNP K._NNP LAHIRI_NNP &_CC CO._NNP ,_, Calcutta_NNP ._.
Messrs._NNP B._NNP BANERJEE_NNP &_CC CO._NNP ,_, Calcutta_NNP ._.
The_DT Calcutta_NNP School_NNP Book_NNP and_CC Useful_NNP Litera-_NNP ture_NN Society_NNP ,_, 1_CD ,_, Wellington_NNP Square_NNP ,_, Calcutta_NNP ._.
Messrs._NNP HIGGINBOTHAM_NNP &_CC CO._NNP ,_, Madras_NNP ._.
Messrs._NNS V._NNP KALYANARAMA_NNP IYER_NNP &_CC CO._NNP ,_, Madras_NNP ._.
Messrs._NNP G._NNP A._NNP NATESAN_NNP &_CC Co._NNP ,_, Madras_NNP ._.
Messrs._NNP S._NNP MURTHY_NNP &_CC CO._NNP ,_, Madras_NNP ._.
Messrs._NNP THOMPSON_NNP &_CC Co._NNP ,_, Madras_NNP ._.
Messrs._NNP TEMPLE_NNP &_CC Co._NNP ,_, Madras_NNP ._.
Messrs._NNP COMBRIDGE_NNP &_CC CO._NNP ,_, Madras_NNP ._.
Messrs._NNS P._NNP R._NNP RAMA_NNP IYER_NNP &_CC CO._NNP ,_, Madras_NNP ._.
Messrs._NNP THACKER_NNP &_CC Co._NNP ,_, LD._NNP ,_, Bombay_NNP ._.
Messrs._NNP A._NNP J._NNP COMBRIDGE_NNP &_CC CO._NNP ,_, Bombay_NNP ._.
Messrs._NNS D._NNP B._NNP TARAPOREVALA_NNP ,_, SONS_NNP &_CC CO._NNP ,_, Bombay_NNP ._.
Mrs._NNP RADHABAI_NNP ATMARAM_NNP SAGOON_NNP ,_, Bombay_NNP ._.
Mr._NNP SUNDER_NNP PANDURANG_NNP ,_, Bombay_NNP ._.
Messrs._NNS GOPAL_NNP NARAYAN_NNP &_CC Co._NNP ,_, Bombay_NNP ._.
Superintendent_NN ,_, American_NNP Baptist_NNP Mission_NNP Press_NNP ,_, Rangoon_NNP ._.
RAI_NNP SAHIB_NNP M._NNP GULAB_NNP SINGH_NNP &_CC SONS_NNP ,_, Mufid-_NNP i-Am_JJ Press_NNP ,_, Lahore_NNP and_CC Calcutta_NNP ._.
Mr._NNP N._NNP B._NNP MATHUR_NNP ,_, Superintendent_NNP ,_, Nazair_NNP Kanun_NNP Hind_NNP Press_NNP ,_, Allahabad_NNP ._.
Messrs._NNP A._NNP CHAND_NNP &_CC Co._NNP ,_, Punjab_NNP ._.
Messrs._NNP A._NNP M._NNP &_CC J._NNP FERGUSON_NNP ,_, Ceylon_NNP ._.
Babu_NNP S._NNP C._NNP TALUKDAR_NNP ,_, Proprietor_NNP ,_, Students_NNS and_CC Company_NNP ,_, Cooch_NNP Behar_NNP ._.
List_NN of_IN numbers_NNS of_IN Scientific_NNP Memoirs_NNP by_IN Officers_NNP of_IN the_DT Medical_NNP and_CC Sanitary_NNP Departments_NNP of_IN the_DT Government_NNP of_IN India_NNP (_( New_NNP Series_NNP )_) published_VBD previous_JJ to_TO the_DT present_JJ issue_NN ._.
No_DT ._.
1_CD ._.
Standardisation_NN of_IN Calmette_NNP 's_POS Anti-Venomous_JJ Serum_NNP with_IN Pure_NNP Cobra_NNP Venom_NNP :_: the_DT Deterioration_NN of_IN this_DT Serum_NNP through_IN keeping_VBG in_IN India_NNP ,_, by_IN Captain_NNP G._NNP Lamb_NNP ,_, I.M.S._NNP ,_, and_CC Wm_NNP ._.
Hanna_NNP ,_, Esq._NNP ,_, M.B_NNP ._.
Price_NN As_IN ._.
3_CD or_CC 4d_CD ._.
No_DT ._.
2_CD ._.
Malaria_NNP in_IN India_NNP ,_, by_IN Captain_NNP S._NNP P._NNP James_NNP ,_, I.M.S._NNP Price_NNP Re_NNP ._.
1-8_CD or_CC 2s_CD ._.
3d_CD ._.
No_DT ._.
3_CD ,_, Some_DT Observations_NNS on_IN the_DT Poison_NNP of_IN Russell_NNP 's_POS Viper_NNP (_( Daboia_NNP Russellii_NNP )_) ,_, by_IN Captain_NNP G._NNP Lamb_NNP ,_, I.M.S._NNP ,_, and_CC Wm_NNP ._.
Hanna_NNP ,_, Esq._NNP ,_, M.B_NNP ._.
Price_NN As_IN ._.
5_CD or_CC 6d_CD ._.
No_DT ._.
4_CD ._.
On_IN the_DT Action_NNP of_IN the_DT Venoms_NNP of_IN the_DT Cobra_NNP and_CC of_IN the_DT Daboia_NNP on_IN the_DT Red_NNP Blood_NNP corpuscles_NNS and_CC on_IN the_DT blood_NN plasma_NN ,_, by_IN Captain_NNP G._NNP Lamb_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
5_CD ._.
Specificity_NN of_IN Anti-Venomous_JJ Sera_NNP ,_, by_IN Captain_NNP G._NNP Lamb_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
3_CD or_CC 4d_CD ._.
No_DT ._.
6_CD ._.
First_NNP Report_NNP on_IN the_DT Anti-Malarial_JJ Operations_NNS in_IN Mian_NNP Mir_NNP ,_, 1901-03_JJ ,_, by_IN Captain_NNP S._NNP P._NNP James_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
12_CD or_CC 1s_CD ._.
2d_CD ._.
No_DT ._.
7_CD ._.
Some_DT Observations_NNS on_IN the_DT Poison_NNP of_IN the_DT Banded_NNP Krait_NNP (_( Bungarus_NNP Fasciatus_NNP )_) ,_, by_IN Captain_NNP G._NNP Lamb_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
8_CD ._.
A_DT Preliminary_JJ Report_NNP on_IN a_DT Parasite_NNP found_VBN in_IN Patients_NNS suffering_VBG from_IN Enlargement_NNP of_IN the_DT Spleen_NNP in_IN India_NNP ,_, by_IN Lieutenant_NNP S._NNP R._NNP Christophers_NNP ,_, I.M.S._NNP Price_NNP Re_NNP ._.
1-8_CD or_CC 2s_CD ._.
3d_CD ._.
No_DT ._.
9_CD ._.
Second_JJ Report_NNP of_IN the_DT Anti-Malarial_JJ Operations_NNS at_IN Mian_NNP Mir_NNP ,_, 1901-03_JJ ,_, by_IN Lieutenant_NNP S._NNP R._NNP Christophers_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
10_CD or_CC 1s_CD ._.
No_DT ._.
10_CD ._.
Specificity_NN of_IN Anti-Venomous_JJ Sera_NNP (_( Second_NNP Communication_NNP )_) ,_, by_IN Captain_NNP G._NNP Lamb_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
11_CD ._.
On_IN a_DT Parasite_NNP found_VBN in_IN persons_NNS suffering_VBG from_IN Enlargement_NNP of_IN the_DT Spleen_NNP in_IN India-_NNP Second_NNP Report_NNP ,_, by_IN Lieutenant_NNP S._NNP R._NNP Christophers_NNP ,_, I.M.S_NNP Price_NNP Rs_NNP ._.
2_CD or_CC 3s_CD ._.
No_DT ._.
12_CD ._.
On_IN the_DT Morphology_NNP ,_, Teratology_NNP ,_, and_CC Diclinism_NNP of_IN the_DT Flowers_NNP of_IN Cannabis_NNP ,_, by_IN Major_NNP D._NNP Prain_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
14_CD or_CC 1s_CD ._.
4d_CD ._.
No_DT ._.
13_CD ._.
Oriental_JJ or_CC Delhi_NNP Sore_NNP ,_, by_IN Captain_NNP S._NNP P._NNP James_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
10_CD or_CC 1s_CD ._.
No_DT ._.
14_CD ._.
On_IN a_DT Parasite_NNP found_NN in_IN the_DT White_NNP Corpuscles_NNPS of_IN the_DT Blood_NNP of_IN Dogs_NNP ,_, by_IN Captain_NNP S._NNP P_NNP ._.
James_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
10_CD or_CC 1s_CD ._.
No_DT ._.
15_CD ._.
On_IN a_DT Parasite_NNP found_VBN in_IN persons_NNS suffering_VBG from_IN Enlargement_NNP of_IN the_DT Spleen_NNP in_IN India-_NNP Third_NNP Report_NNP ,_, by_IN Lieutenant_NNP S._NNP R._NNP Christophers_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
10_CD or_CC 1s_CD ._.
No_DT ._.
16_CD ._.
The_DT Specificity_NNP of_IN Anti-Venomous_NNP Sera_NNP with_IN special_JJ reference_NN to_TO a_DT Serum_NNP prepared_VBN with_IN the_DT Venom_NNP of_IN the_DT Daboia_NNP Russellii_NNP ,_, by_IN Captain_NNP G._NNP Lamb_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
6_CD or_CC 7d_CD ._.
No_DT ._.
17_CD ._.
Snake-Venoms_NNS in_IN relation_NN to_TO Hæmolysis_NNP ,_, by_IN Captain_NNP G._NNP Lamb_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
6_CD or_CC 7d_CD ._.
No_DT ._.
18_CD ._.
Hæmogregarina_NNP Gerbilli_NNP ,_, by_IN Lieutenant_NNP S._NNP R._NNP Christophers_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
10_CD or_CC 1s_CD ._.
No_DT ._.
19_CD ._.
On_IN Kala_NNP Azar_NNP ,_, Malaria_NNP and_CC Malarial_NNP Cachexia_NNP ,_, by_IN Captain_NNP S._NNP P._NNP James_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP Re_NNP ._.
1-4_CD or_CC 1s_CD ._.
11d_CD ._.
No_DT ._.
20_CD ._.
Serum-Therapy_NN of_IN Plague_NNP in_IN India_NNP ;_: Reports_NNS by_IN Mr._NNP W._NNP M._NNP Haffkine_NNP ,_, C.I.E._NNP ,_, and_CC various_JJ officers_NNS of_IN the_DT Plague_NNP Research_NNP Laboratory_NNP ,_, Bombay_NNP ,_, by_IN Lieutenant-_NNP Colonel_NNP W._NNP B._NNP Bannerman_NNP ,_, M.D._NNP ,_, B.Sc._NNP ,_, F.R.C.S._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
14_CD or_CC 1s_CD ._.
4d_CD ._.
No_DT ._.
21_CD ._.
On_IN the_DT Standardisation_NNP of_IN Anti-Typhoid_NNP Vaccine_NNP ,_, by_IN Captain_NNP George_NNP Lamb_NNP ,_, M.D._NNP ,_, I.M.S._NNP (_( Director_NNP ,_, Pasteur_NNP Institute_NNP of_IN India_NNP )_) ,_, and_CC Captain_NNP W_NNP B._NNP C._NNP Forster_NNP ,_, M.B._NNP ,_, D.P.H._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
6_CD or_CC 7d_CD ._.
2_CD No_DT ._.
22_CD ._.
Mediterranean_JJ Fever_NNP in_IN India_NNP :_: Isolation_NN of_IN the_DT Micrococcus_NNP Melitensis_NNP ,_, by_IN Captain_NNP George_NNP Lamb_NNP ,_, M.D._NNP ,_, I.M.S._NNP ,_, and_CC Assistant_NNP Surgeon_NNP M._NNP Kesava_NNP Pai_NNP ,_, M.B._NNP ,_, C.M_NNP ._.
(_( Madras_NNP )_) ._.
Price_NN As_IN ._.
10_CD or_CC 1s_CD ._.
No_DT ._.
23_CD ._.
The_DT Anatomy_NNP and_CC Histology_NNP of_IN Ticks_NNP ,_, by_IN Captain_NNP S._NNP R._NNP Christophers_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP Rs_NNP ._.
3_CD or_CC 4s_CD ._.
6d_CD ._.
No_DT ._.
24_CD ._.
On_IN a_DT Parasite_NNP found_NN in_IN the_DT White_NNP Corpuscles_NNPS of_IN the_DT blood_NN of_IN Palm_NNP Squirrels_NNP ,_, by_IN Captain_NNP W._NNP S._NNP Patton_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
12_CD or_CC 1s_CD ._.
2d_CD ._.
No_DT ._.
25_CD ._.
On_IN the_DT importance_NN of_IN Larval_NNP Characters_NNP in_IN the_DT Classification_NNP of_IN Mosquitoes_NNP ,_, by_IN Captain_NNP S._NNP R._NNP Christophers_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
26_CD ._.
Leucocytozoon_NNP Canis_NNP ,_, by_IN Captain_NNP S._NNP R._NNP Christophers_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
12_CD or_CC 1s_CD ._.
2d_CD ._.
No_DT ._.
27_CD ._.
Preliminary_JJ Report_NNP on_IN the_DT Development_NNP of_IN the_DT Leishman-Donovan_NNP Body_NNP in_IN the_DT Bed_NNP Bug_NNP ,_, by_IN Captain_NNP W._NNP S._NNP Patton_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
28_CD ._.
The_DT Sexual_JJ Cycle_NNP of_IN Leucocytozoon_NNP Canis_NNP in_IN the_DT Tick_NNP ,_, by_IN Captain_NNP S._NNP R._NNP Christophers_NNP ,_, M.B_NNP ._.
I.M.S._JJ Price_NNP As_NNP ._.
12_CD or_CC 1s_CD ._.
2d_CD ._.
No_DT ._.
29_CD ,_, Piroplasma_NNP Canis_NNP and_CC its_PRP$ Cycle_NNP in_IN the_DT Tick_NNP ,_, by_IN Captain_NNP S._NNP R._NNP Christophers_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP Rs_NNP ._.
2_CD or_CC 3s_CD ._.
No_DT ._.
30_CD ._.
The_DT Theory_NNP and_CC Practice_NNP of_IN Anti-Rabic_NNP Immunisation_NNP ,_, by_IN Captain_NNP W._NNP F._NNP Harvey_NNP ,_, M.B._NNP ,_, I.M.S._NNP ,_, and_CC Captain_NNP Anderson_NNP McKendrick_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
12_CD or_CC 1s_CD ._.
2d_CD ._.
No_DT ._.
31_CD ._.
The_DT Development_NNP of_IN the_DT Leishman-Donovan_NNP Parasite_NNP in_IN Cimex_NNP Rotundatus-Second_NNP Report_NNP ,_, by_IN Captain_NNP W._NNP S._NNP Patton_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP Re_NNP ._.
1_CD or_CC 1s_CD ._.
6d_CD ._.
No_DT ._.
32_CD ._.
An_DT Enquiry_NNP on_IN Enteric_NNP Fever_NNP in_IN India_NNP carried_VBD out_RP at_IN the_DT Central_NNP Research_NNP Institute_NNP ,_, Kasauli_NNP ,_, under_IN the_DT direction_NN of_IN Lieutenant-Colonel_NNP D._NNP Semple_NNP ,_, M.D._NNP ,_, and_CC Captain_NNP E._NNP D._NNP W._NNP Greig_NNP ,_, M.D_NNP ._.
Price_NNP Re_NNP ._.
1-2_CD or_CC 1s_CD ._.
9d_CD ._.
No_DT ._.
33_CD ._.
The_DT Production_NN of_IN Alkali_NNP in_IN Liquid_NNP Media_NNP by_IN the_DT Bacillus_NNP Pestis_NNP ,_, by_IN Lieutenant-_NNP Colonel_NNP W._NNP B._NNP Bannerman_NNP ,_, M.D._NNP ,_, B.Sc._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
5_CD or_CC 6d_CD ._.
No_DT ._.
34_CD ._.
Standards_NNS of_IN the_DT Constituents_NNS of_IN the_DT Urine_NNP and_CC Blood_NNP and_CC the_DT bearing_NN of_IN the_DT Meta-_NNP bolism_NN of_IN Bengalis_NNP on_IN the_DT Problems_NNP of_IN Nutrition_NNP ,_, by_IN Captain_NNP D._NNP McCay_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
12_CD or_CC Is_NNP ._.
2d_CD ._.
No_DT ._.
35_CD ._.
Black-water_NNP Fever_NNP ,_, by_IN Captain_NNP S._NNP R._NNP Christophers_NNP ,_, M.B._NNP ,_, I.M.S._NNP ,_, and_CC Dr._NNP C._NNP A._NNP Bentley_NNP ._.
No_DT ._.
36_CD ._.
Observations_NNS on_IN Rabies_NNS :_: with_IN special_JJ reference_NN to_TO an_DT Atrophic_JJ form_NN of_IN the_DT disease_NN occurring_VBG in_IN animals_NNS ,_, by_IN Major_NNP G._NNP Lamb_NNP ,_, M.D._NNP ,_, I.M.S._NNP ,_, and_CC Captain_NNP A._NNP G._NNP McKendrick_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
37_CD ._.
Investigations_NNS on_IN Bengal_NNP Jail_NNP Dietaries_NNS :_: with_IN some_DT observations_NNS on_IN the_DT influence_NN of_IN dietary_NN on_IN the_DT physical_JJ development_NN ent_NN and_CC well-being_NN of_IN the_DT people_NNS of_IN Bengal_NNP ,_, by_IN Captain_NNP D._NNP McCay_NNP ,_, M.B._NNP ,_, B.Ch._NNP ,_, B.A.O._NNP ,_, I.M.S._NNP Price_NNP Rs_NNP ._.
2-6_JJ or_CC 4s_CD ._.
3d_CD ._.
No_DT ._.
38_CD ._.
Preliminary_JJ Report_NNP on_IN the_DT killing_NN of_IN Rats_NNP and_CC Rat_NNP Fleas_NNP by_IN Hydrocyanic_NNP Acid_NNP Gas_NNP ,_, by_IN Captain_NNP W._NNP D._NNP H._NNP Stevenson_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
39_CD ._.
The_DT Applicability_NNP to_TO Medico-Legal_NNP Practice_NNP in_IN India_NNP of_IN the_DT Biochemical_NNP ._.
Tests_NNS for_IN the_DT Origin_NNP of_IN Blood-Stains_NNP ,_, by_IN Lieutenant-Colonel_NNP W._NNP D._NNP Sutherland_NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
40_CD ._.
The_DT Destruction_NNP of_IN Fleas_NNP by_IN Exposure_NNP to_TO the_DT Sun_NNP ,_, by_IN Captain_NNP J._NNP Cunningham_NNP ,_, M.D._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
41_CD ._.
Quinine_NNP and_CC its_PRP$ Salts_NNP ,_, their_PRP$ Solubility_NN and_CC Absorbability_NNP ,_, by_IN Captain_NNP A._NNP C._NNP MacGilchrist_NNP ,_, M.A._NNP ,_, M.D._NNP ,_, M.R.C.P._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
9_CD or_CC 10d_CD ._.
No_DT ._.
42_CD ._.
The_DT Cultivation_NNP of_IN the_DT Bacillus_NNP of_IN Leprosy_NNP and_CC the_DT Treatment_NNP of_IN cases_NNS by_IN means_NNS of_IN a_DT Vaccine_NNP prepared_VBN from_IN the_DT Cultivations_NNP ,_, by_IN Major_NNP E._NNP R._NNP Rost_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
43_CD ._.
The_DT Relation_NNP of_IN Tetanus_NNP to_TO the_DT Hypodermic_NNP or_CC Intramuscular_NNP ._.
Injection_NN of_IN Quinine_NNP ,_, by_IN Lieutenant-Colonel_NNP Sir_NNP D._NNP Semple_NNP ,_, Kt._NNP ,_, M.D_NNP ._.
Price_NN As_IN ._.
12_CD or_CC 1s_CD ._.
2d_CD ._.
Published_VBN by_IN and_CC on_IN sale_NN at_IN the_DT Office_NNP of_IN the_DT Superintendent_NNP of_IN Government_NNP Printing_NNP ,_, India_NNP ,_, Calcutta_NNP ._.
Copies_NNS are_VBP also_RB available_JJ from_IN all_DT Agents_NNS for_IN the_DT sale_NN of_IN Government_NNP publications_NNS ._.
CONTENTS_NNS ._.
CHAPTER_NN I_PRP ._.
PAGE_NN ._.
INTRODUCTION_NNP 1_CD CHAPTER_NNP II_NNP ._.
THE_DT EFFECT_NNP OF_NNP HEAT_NNP ON_NNP RABIES_NNP VIRUS_NNP 6_CD CHAPTER_NNP III_NNP ._.
THE_DT EFFECT_NNP OF_NNP CARBOLIC_NNP ACID_NNP ON_NNP RABIES_NNP VIRUS_NNP 8_CD CHAPTER_NNP IV_NNP ._.
THE_DT EFFECT_NNP OF_NNP NORMAL_NNP SALINE_NNP SOLUTION_NNP ON_NNP RABIES_NNP VIRUS_NNP :_: 1_CD ._.
At_IN Room_NNP Temperature_NNP ._.
14_CD 2_CD ._.
At_IN a_DT Temperature_NN of_IN 37°C_CD ._.
15_CD CHAPTER_NN V._NNP THE_NNP IMMUNISATION_NNP OF_NNP ANIMALS_NNP WITH_NNP RABIES_NNP VIRUS_NNP KILLED_NNP BY_NNP CARBOLIC_NNP ACID_NNP ,_, AND_NNP THEIR_NNP SUBSEQUENT_NNP RESISTANCE_NNP TO_NNP THE_NNP SUBDURAL_NNP INOCULATION_NNP OF_NNP LETHAL_NNP DOSES_NNP OF_IN ``_`` STREET_NNP VIRUS_NNP ,_, ''_'' AND_NNP ALSO_NNP OF_NNP ``_`` FIXED_NNP VIRUS_NNP ._. ''_''
18_CD CHAPTER_NN VI_NNP ._.
THE_DT EVIDENCE_NNP OF_NNP IMMUNITY_NNP IN_NNP THE_NNP SERUM_NNP OF_NNP ANIMALS_NNP TREATED_NNP WITH_NNP RABIES_NNP VIRUS_NNP KILLED_NNP BY_NNP CARBOLIC_NNP ACID_NNP 26_CD CHAPTER_NNP VII_NNP ._.
THE_DT ADVANTAGES_NNP OF_NNP HAVING_NNP A_NNP SAFE_NNP AND_NNP EFFICIENT_NNP ANTIRABIC_NNP VACCINE_NNP WHICH_NNP COULD_NNP BE_NNP SENT_NNP TO_NNP WHEREVER_NNP IT_NNP IS_NNP REQUIRED_NNP FOR_IN THE_NNP TREATMENT_NNP OF_NNP PATIENTS_NNP 29_CD CHAPTER_NNP VIII_NNP ._.
SUMMARY_NNP OF_NNP CONCLUSIONS_NNP ._.
32_CD B_NNP The_DT Preparation_NNP of_IN a_DT Safe_NNP and_CC Efficient_NNP Antirabic_NNP Vaccine_NNP ._.
CHAPTER_NN I_PRP ._.
Introduction_NNP THE_NNP two_CD cardinal_JJ factors_NNS to_TO be_VB taken_VBN into_IN consideration_NN in_IN the_DT preparation_NN and_CC administration_NN of_IN vaccines_NNS whether_IN for_IN prophylactic_JJ or_CC curative_JJ purposes_NNS are_VBP ,_, safety_NN and_CC efficiency_NN ._.
When_WRB Pasteur_NNP first_RB applied_VBD his_PRP$ method_NN of_IN antirabic_JJ treatment_NN to_TO man_NN these_DT were_VBD the_DT two_CD points_NNS upon_IN which_WDT he_PRP concentrated_VBD his_PRP$ attention_NN ,_, with_IN the_DT result_NN that_IN he_PRP firmly_RB established_VBD the_DT principles_NNS of_IN antirabic_JJ treatment_NN now_RB carried_VBN out_RP in_IN almost_RB every_DT civilised_JJ country_NN where_WRB rabies_NNS is_VBZ found_VBN ._.
In_IN the_DT practice_NN of_IN conferring_VBG a_DT specific_JJ immunity_NN on_IN man_NN and_CC animals_NNS by_IN ino-_JJ culating_VBG them_PRP with_IN dead_JJ bacterial_JJ vaccines_NNS ,_, the_DT question_NN of_IN safety_NN ,_, or_CC free-_JJ dom_NN from_IN any_DT risk_NN of_IN communicating_VBG the_DT disease_NN which_WDT the_DT vaccine_NN is_VBZ intended_VBN to_TO prevent_VB is_VBZ foreclosed_VBN ,_, and_CC the_DT main_JJ points_NNS to_TO be_VB taken_VBN into_IN consideration_NN are_VBP a_DT proper_JJ system_NN of_IN dosage_NN ,_, and_CC the_DT interspacing_NN of_IN doses_NNS ;_: but_CC when_WRB living_NN vaccines_NNS are_VBP used_VBN the_DT question_NN assumes_VBZ a_DT different_JJ aspect_NN ._.
It_PRP is_VBZ now_RB well_RB established_VBN that_IN dead_JJ bacterial_JJ vaccines_NNS are_VBP efficient_JJ in_IN producing_VBG an_DT immunising_JJ response_NN in_IN man_NN and_CC animals_NNS ;_: a_DT response_NN which_WDT in_IN most_JJS cases_NNS it_PRP would_MD not_RB be_VB justifiable_JJ to_TO attempt_VB to_TO produce_VB with_IN living_NN bacteria_NNS ._.
On_IN this_DT account_NN it_PRP is_VBZ now_RB almost_RB the_DT universal_JJ custom_NN in_IN the_DT prophylactic_JJ and_CC cura-_JJ tive_JJ vaccination_NN of_IN infectious_JJ diseases_NNS in_IN man_NN to_TO make_VB use_NN of_IN killed_JJ cultures_NNS of_IN the_DT causal_JJ micro-organisms_NNS ._.
No_DT person_NN would_MD be_VB justified_VBN in_IN using_VBG a_DT living_NN staphylo-_JJ coccus_NN ,_, or_CC a_DT living_JJ streptococcus_NN vaccine_NN ,_, when_WRB dead_JJ vaccines_NNS prepared_VBN from_IN these_DT germs_NNS answer_VBP every_DT purpose_NN ._.
In_IN the_DT immunisation_NN of_IN animals_NNS it_PRP is_VBZ not_RB an_DT uncommon_JJ practice_NN to_TO begin_VB by_IN using_VBG dead_JJ bacterial_JJ cultures_NNS ,_, and_CC then_RB go_VB on_IN to_TO living_VBG cultures_NNS ;_: but_CC in_IN man_NN it_PRP is_VBZ exceptional_JJ to_TO use_VB living_NN microbes_NNS either_CC for_IN prophylactic_JJ or_CC curative_JJ purposes_NNS ,_, although_IN in_IN some_DT cases_NNS it_PRP has_VBZ been_VBN done_VBN with_IN perfect_JJ safety_NN ,_, e.g._NN ,_, in_IN the_DT prophylaxis_NN of_IN cholera_NN and_CC typhoid_NN fever_NN ._.
In_IN some_DT cases_NNS an_DT attenuated_JJ living_NN vaccine_NN is_VBZ used_VBN as_IN a_DT prophylactic_JJ by_IN communicating_VBG a_DT modified_JJ form_NN of_IN the_DT disease_NN ,_, e.g._NN ,_, vaccinia_NN to_TO protect_VB against_IN small-pox_JJ in_IN man_NN ;_: but_CC in_IN this_DT particular_JJ case_NN the_DT person_NN inocula-_JJ ted_VBN can_MD afford_VB to_TO allow_VB the_DT virus_NN to_TO multiply_VB without_IN running_VBG any_DT risks_NNS ,_, and_CC more-_NN over_IN ,_, the_DT multiplication_NN of_IN the_DT living_NN element_NN in_IN this_DT vaccine_NN is_VBZ no_DT doubt_NN the_DT strong-_JJ B2_NNP 2_CD est_JJS point_NN in_IN favour_NN of_IN its_PRP$ efficiency_NN ._.
In_IN the_DT other_JJ two_CD examples_NNS given_VBN ,_, viz._NN ,_, in_IN the_DT prophylaxis_NN of_IN cholera_NN and_CC typhoid_NN fever_NN in_IN man_NN ,_, in_IN which_WDT living_VBG vaccines_NNS have_VBP been_VBN injected_VBN subcutaneously_RB ,_, a_DT multiplication_NN is_VBZ the_DT last_JJ thing_NN to_TO be_VB desired_VBN ,_, and_CC as_RB far_RB as_IN we_PRP know_VBP it_PRP does_VBZ not_RB take_VB place_NN when_WRB these_DT vaccines_NNS are_VBP given_VBN subcutaneously_RB ;_: but_CC even_RB so_RB ,_, it_PRP is_VBZ now_RB the_DT custom_NN in_IN the_DT prophylaxis_NN of_IN typhoid_NN and_CC cholera_NN to_TO use_VB only_RB dead_JJ bacterial_JJ cultures_NNS ._.
When_WRB we_PRP apply_VBP these_DT facts_NNS to_TO antirabic_VB treatment_NN ,_, the_DT subject_NN assumes_VBZ an_DT aspect_JJ worthy_NN of_IN careful_JJ consideration_NN ,_, because_IN the_DT multiplication_NN of_IN a_DT living_NN rabies_NNS virus_RB intended_VBD as_IN a_DT prophylactic_JJ vaccine_NN would_MD mean_VB hydrophobia_NN and_CC death_NN to_TO the_DT person_NN inoculated_VBD ._.
Pasteur_NN recognised_VBD this_DT danger_NN ,_, and_CC provided_VBD against_IN its_PRP$ occurrence_NN by_IN com-_JJ mencing_NN treatment_NN with_IN a_DT dead_JJ virus_NN ,_, followed_VBN by_IN an_DT attenuated_JJ living_NN virus_NN ._.
By_IN this_DT means_VBZ he_PRP was_VBD able_JJ to_TO commence_VB the_DT immunisation_NN of_IN his_PRP$ patients_NNS with_IN a_DT vac-_JJ cine_NN which_WDT was_VBD perfectly_RB safe_JJ and_CC which_WDT established_VBD a_DT degree_NN of_IN immunity_NN suffi-_JJ cient_NN to_TO render_VB the_DT subsequent_JJ injection_NN of_IN living_NN and_CC virulent_NN virus_NN also_RB quite_RB safe_JJ ._.
Sometime_RB after_IN Pasteur_NNP inaugurated_VBD his_PRP$ system_NN ,_, Högyes_NNP of_IN Buda-Pesth_NNP in-_NN troduced_VBD a_DT method_NN of_IN antirabic_JJ treatment_NN by_IN injecting_VBG high_JJ dilutions_NNS of_IN living_NN and_CC virulent_JJ virus_NN to_TO begin_VB with_IN ,_, gradually_RB going_VBG on_IN to_TO lower_VB dilutions_NNS ._.
This_DT method_NN has_VBZ been_VBN adopted_VBN by_IN several_JJ Pasteur_NNP Institutes_NNPS ,_, and_CC has_VBZ been_VBN reported_VBN upon_IN favour-_NN ably_NN by_IN some_DT observers_NNS ._.
It_PRP has_VBZ the_DT merit_NN of_IN being_VBG easier_JJR to_TO carry_VB out_RP ,_, and_CC is_VBZ less_RBR expensive_JJ than_IN the_DT treatment_NN advocated_VBN by_IN Pasteur_NNP and_CC his_PRP$ followers_NNS ;_: but_CC whether_IN it_PRP is_VBZ the_DT best_JJS and_CC safest_JJS method_NN that_IN science_NN can_MD devise_VB in_IN the_DT absence_NN of_IN exact_JJ knowledge_NN about_IN the_DT causal_JJ micro-organism_NN of_IN rabies_NNS ,_, is_VBZ a_DT disputed_JJ point_NN ._.
We_PRP know_VBP that_IN rabies_NNS is_VBZ due_JJ to_TO a_DT living_NN virus_NN which_WDT has_VBZ never_RB been_VBN cultivated_VBN outside_IN the_DT tissues_NNS of_IN man_NN or_CC animals_NNS suffering_VBG from_IN the_DT disease_NN ;_: we_PRP also_RB know_VBP that_IN many_JJ of_IN the_DT symptoms_NNS present_JJ in_IN rabies_NNS resemble_VBP those_DT present_JJ in_IN cases_NNS of_IN tetanus_NN ._.
In_IN tetanus_CC the_DT symptoms_NNS depend_VBP upon_IN extra-cellular_JJ toxines_NNS elaborated_VBN by_IN the_DT tetanus_NN bacillus_NN ;_: but_CC whether_IN any_DT or_CC all_DT of_IN the_DT symptoms_NNS of_IN rabies_NNS depend_VBP upon_IN extra-cellular_JJ toxines_NNS elaborated_VBN by_IN the_DT causal_NN micro-organism_NN in_IN a_DT manner_NN somewhat_RB similar_JJ to_TO those_DT of_IN tetanus_NN is_VBZ a_DT subject_NN about_IN which_WDT we_PRP know_VBP practically_RB nothing_NN ,_, and_CC we_PRP are_VBP not_RB likely_JJ to_TO gain_VB much_JJ information_NN on_IN this_DT point_NN until_IN it_PRP be-_JJ comes_VBZ possible_JJ to_TO cultivate_VB the_DT causal_JJ micro-organism_NN of_IN rabies_NNS in_IN artificial_JJ media_NNS ,_, and_CC to_TO experiment_VB with_IN pure_JJ cultures_NNS separate_VBP from_IN the_DT nerve_NN tissue_NN of_IN animals_NNS dead_JJ of_IN the_DT disease_NN ._.
In_IN the_DT meantime_NN it_PRP only_RB remains_VBZ to_TO follow_VB the_DT lines_NNS laid_VBD down_RB by_IN Pasteur_NNP ,_, but_CC modified_VBD in_IN accordance_NN with_IN the_DT experience_NN gained_VBN from_IN recent_JJ advances_NNS in_IN our_PRP$ knowledge_NN of_IN prophylactic_JJ inoculations_NNS in_IN other_JJ diseases_NNS ._.
Those_DT who_WP advocate_VBP the_DT ``_`` dilution_NN method_NN ``_`` (_( Högyes_NNP '_POS method_NN )_) of_IN treatment_NN take_VB it_PRP for_IN granted_VBN that_IN a_DT rabies_NNS toxine_VBP separate_JJ from_IN the_DT living_VBG virus_NN does_VBZ not_RB exist_VB ;_: 3_CD and_CC those_DT who_WP advocate_VBP the_DT ``_`` dried_JJ cord_NN method_NN ``_`` (_( Pasteur_NNP 's_POS method_NN )_) keep_VB in_IN view_NN the_DT possibility_NN of_IN the_DT existence_NN of_IN a_DT toxine_NN in_IN the_DT nerve_NN centres_NNS (_( brain_NN and_CC spinal_JJ cord_NN )_) ,_, the_DT principal_JJ seat_NN of_IN the_DT virus_NN and_CC where_WRB it_PRP multiplies_VBZ ._.
Moreover_RB ,_, there_EX is_VBZ another_DT point_NN which_WDT influences_VBZ the_DT selection_NN of_IN a_DT method_NN of_IN treatment_NN ,_, viz._NN ,_, the_DT attenuation_NN of_IN rabies_NNS virus_NNS ._.
In_IN the_DT dried_JJ cord_NN method_NN of_IN preparing_VBG a_DT vaccine_NN ,_, attenuation_NN of_IN the_DT virus_NN is_VBZ supposed_VBN to_TO take_VB place_NN from_IN day_NN to_TO day_NN ,_, and_CC strictly_RB in_IN accordance_NN with_IN the_DT length_NN of_IN time_NN the_DT cord_NN has_VBZ been_VBN dried_VBN under_IN fixed_JJ conditions_NNS ;_: but_CC here_RB ,_, again_RB ,_, the_DT oc-_JJ currence_NN of_IN attenuation_NN is_VBZ denied_VBN by_IN some_DT and_CC firmly_RB believed_VBN in_IN by_IN others_NNS ._.
It_PRP would_MD serve_VB no_DT useful_JJ purpose_NN to_TO enumerate_VB the_DT arguments_NNS for_IN and_CC against_IN these_DT different_JJ views_NNS ._.
The_DT cultivation_NN of_IN the_DT virus_NN in_IN artificial_JJ media_NNS (_( should_MD this_DT ever_RB become_VBN possible_JJ )_) is_VBZ the_DT source_NN from_IN which_WDT the_DT gaps_NNS in_IN our_PRP$ knowledge_NN about_IN rabies_NNS virus_NNS are_VBP likely_JJ to_TO be_VB filled_VBN in_IN and_CC until_IN this_DT has_VBZ been_VBN accomplished_VBN the_DT views_NNS of_IN workers_NNS on_IN rabies_NNS are_VBP sure_JJ to_TO differ_VB widely_RB ._.
Setting_VBG aside_RP these_DT two_CD methods_NNS of_IN preparing_VBG an_DT antirabic_JJ vaccine_NN ,_, viz._NN ,_, the_DT ``_`` dried_JJ cord_NN method_NN ``_`` and_CC the_DT ``_`` dilution_NN method_NN ,_, ''_'' in_IN both_DT of_IN which_WDT a_DT living_NN virus_NN is_VBZ used_VBN ,_, are_VBP there_RB any_DT other_JJ possible_JJ methods_NNS of_IN preparing_VBG a_DT safe_JJ and_CC efficient_JJ vaccine_NN ?_.
As_IN I_PRP have_VBP already_RB stated_VBN dead_JJ vaccines_NNS have_VBP been_VBN found_VBN safe_JJ and_CC efficient_JJ in_IN ._.
the_DT prophylaxis_NN of_IN other_JJ diseases_NNS ,_, why_WRB should_MD not_RB similar_JJ methods_NNS apply_VBP to_TO rabies_NNS ?_.
With_IN the_DT object_NN of_IN throwing_VBG some_DT light_JJ upon_IN this_DT important_JJ question_NN the_DT ex-_JJ periments_NNS upon_IN which_WDT this_DT paper_NN is_VBZ based_VBN were_VBD carried_VBN out_RP ._.
In_IN a_DT word_NN ,_, my_PRP$ object_NN was_VBD to_TO ascertain_VB whether_IN animals_NNS can_MD be_VB as_IN highly_RB immunised_VBN with_IN a_DT dead_JJ virus_NN as_IN with_IN a_DT living_NN virus_NN and_CC if_IN this_DT is_VBZ possible_JJ it_PRP would_MD naturally_RB follow_VB that_DT such_PDT a_DT vaccine_NN would_MD be_VB safe_JJ and_CC efficient_JJ ,_, two_CD most_RBS important_JJ and_CC essential_JJ properties_NNS in_IN an_DT antirabic_JJ vaccine_NN ,_, or_CC in_IN any_DT other_JJ vaccine_NN ._.
We_PRP know_VBP that_DT heat_NN is_VBZ a_DT damaging_JJ agent_NN to_TO use_VB in_IN killing_VBG bacterial_JJ vaccines_NNS when_WRB it_PRP is_VBZ necessary_JJ to_TO store_VB them_PRP for_IN some_DT time_NN before_IN use_NN ;_: and_CC that_IN carbolic_JJ acid_NN in_IN weak_JJ dilutions_NNS is_VBZ a_DT reliable_JJ agent_NN for_IN sterilising_VBG bacterial_JJ vaccines_NNS without_IN lessening_VBG their_PRP$ immunising_NN and_CC keeping_VBG properties_NNS ._.
1_CD On_IN the_DT other_JJ hand_NN ,_, a_DT low_JJ degree_NN of_IN heat_NN ,_, any_DT temperature_NN below_IN 60°C_CD ,_, applied_VBN from_IN 15_CD to_TO 30_CD minutes_NNS does_VBZ not_RB materially_RB diminish_VB the_DT immunising_NN properties_NNS of_IN a_DT bacterial_JJ vaccine_NN intended_VBN for_IN early_JJ use_NN ;_: but_CC after_IN heating_VBG it_PRP is_VBZ always_RB necessary_JJ to_TO add_VB an_DT antiseptic_JJ when_WRB the_DT vaccine_NN has_VBZ to_TO be_VB stored_VBN ,_, or_CC sent_VBD out_RP for_IN use_NN ._.
In_IN those_DT vaccines_NNS which_WDT are_VBP easily_RB killed_VBN in_IN a_DT small_JJ percentage_NN of_IN an_DT antisep-_JJ tic_JJ ,_, such_JJ as_IN from_IN 0.5_CD to_TO 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ,_, it_PRP is_VBZ unnecessary_JJ to_TO use_VB heat_NN at_IN all_DT ,_, because_IN it_PRP would_MD not_RB do_VB away_RB with_IN the_DT necessity_NN of_IN afterwards_NNS adding_VBG an_DT anti-_JJ 1_CD Semple_NNP &_CC Matson_NNP :_: On_IN the_DT Preparation_NNP and_CC Keeping_NNP Properties_NNP of_IN Antityphoid_NNP Vaccines.4_NNP septic_JJ to_TO preserve_VB the_DT vaccine_NN ,_, and_CC to_TO guard_VB against_IN any_DT subsequent_JJ contamina-_JJ tion_NN ._.
In_IN preparing_VBG a_DT dead_JJ antirabic_JJ vaccine_NN it_PRP was_VBD necessary_JJ to_TO make_VB a_DT choice_NN between_IN these_DT two_CD methods_NNS ,_, viz._NN ,_, heat_NN followed_VBN by_IN an_DT antiseptic_JJ ,_, or_CC an_DT antiseptic_JJ only_RB ._.
In_IN the_DT experiments_NNS which_WDT follow_VBP it_PRP will_MD be_VB seen_VBN that_IN the_DT rabies_NNS virus_NN is_VBZ easily_RB killed_VBN by_IN heat_NN ,_, and_CC that_IN a_DT temperature_NN of_IN 50°C_CD for_IN 15_CD minutes_NNS is_VBZ sufficient_JJ to_TO des-_JJ troy_NN it_PRP ._.
It_PRP will_MD also_RB be_VB seen_VBN that_IN it_PRP is_VBZ more_RBR resistant_JJ to_TO carbolic_JJ acid_NN at_IN room_NN tem-_NN perature_NN than_IN most_JJS non-spore_JJ forming_NN bacteria_NNS ;_: but_CC at_IN a_DT temperature_NN of_IN 37°C_CD it_PRP is_VBZ easily_RB killed_VBN in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ._.
Of_IN these_DT two_CD methods_NNS of_IN killing_VBG a_DT vaccine_NN ,_, viz._NN ,_, by_IN heat_NN ,_, and_CC by_IN carbolic_JJ acid_NN ,_, carbolic_JJ acid_NN is_VBZ the_DT one_CD which_WDT produces_VBZ least_JJS change_NN in_IN the_DT vaccine.1_NN When_WRB heat_NN is_VBZ employed_VBN we_PRP make_VBP use_NN of_IN an_DT agent_NN of_IN the_DT effect_NN of_IN which_WDT we_PRP know_VBP nothing_NN whatever_NN ,_, except_IN that_IN it_PRP kills_VBZ the_DT living_NN element_NN ,_, and_CC that_IN bacterial_JJ vac-_JJ cines_NNS killed_VBN by_IN heat_NN retain_VBP their_PRP$ immunising_NN properties_NNS for_IN a_DT shorter_JJR period_NN than_IN similar_JJ vaccines_NNS killed_VBN by_IN carbolic_JJ acid_NN ._.
For_IN these_DT reasons_NNS it_PRP was_VBD decided_VBN to_TO experiment_VB with_IN a_DT vaccine_NN prepared_VBN by_IN killing_VBG the_DT virus_NN in_IN 8_CD per_IN cent_NN ._.
dilutions_NNS in_IN normal_JJ saline_JJ solution_NN to_TO which_WDT had_VBD been_VBN added_VBN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ._.
Twenty-four_JJ hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD was_VBD found_VBN to_TO be_VB sufficient_JJ to_TO kill_VB the_DT virus_NN in_IN 8_CD per_IN cent_NN ,_, dilutions_NNS when_WRB 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN had_VBD been_VBN added_VBN ._.
After_IN 24_CD hours_NNS the_DT killed_JJ vaccine_NN was_VBD diluted_VBN with_IN an_DT equal_JJ volume_NN of_IN sterile_JJ normal_JJ saline_JJ solution_NN ,_, and_CC kept_VBD at_IN room_NN temper-_JJ ature_NN for_IN use_NN when_WRB required_VBN ._.
This_DT gave_VBD a_DT 4_CD per_IN cent_NN ._.
dilution_NN of_IN virus_NN in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN a_DT dilution_NN suitable_JJ for_IN treatment_NN pur-_JJ poses_NNS ,_, or_CC which_WDT could_MD be_VB still_RB more_RBR diluted_JJ if_IN considered_VBN necessary_JJ ._.
In_IN a_DT preparation_NN of_IN this_DT kind_NN the_DT vaccine_NN will_MD keep_VB for_IN months_NNS ,_, and_CC retain_VB its_PRP$ immunising_NN properties_NNS unimpaired_VBD ,_, provided_VBD that_IN it_PRP is_VBZ kept_VBN in_IN a_DT moderately_RB cool_JJ place_NN screened_VBD from_IN light_NN ._.
That_IN it_PRP is_VBZ a_DT safe_JJ and_CC efficient_JJ vaccine_NN in_IN the_DT immunisa-_JJ tion_NN of_IN animals_NNS the_DT experiments_NNS recorded_VBN in_IN this_DT paper_NN afford_NN ample_JJ proof_NN ._.
It_PRP also_RB possesses_VBZ the_DT great_JJ advantage_NN that_IN it_PRP could_MD be_VB sent_VBN from_IN the_DT labora-_JJ tory_NN where_WRB it_PRP is_VBZ prepared_JJ to_TO places_NNS at_IN a_DT distance_NN where_WRB any_DT medical_JJ man_NN with_IN a_DT good_JJ knowledge_NN of_IN the_DT administration_NN of_IN vaccines_NNS could_MD carry_VB out_RP the_DT treatment_NN of_IN patients_NNS bitten_VBN by_IN rabid_NN animals_NNS ._.
When_WRB we_PRP realise_VBP what_WP this_DT means_VBZ in_IN a_DT country_NN like_IN India_NNP ,_, where_WRB rabies_NNS is_VBZ so_RB widely_RB scattered_JJ and_CC of_IN common_JJ occurrence_NN ,_, the_DT ad-_JJ vantages_NNS of_IN such_PDT a_DT system_NN in_IN providing_VBG a_DT safe_JJ and_CC efficient_JJ vaccine_NN are_VBP enormous_JJ ._.
Instead_RB of_IN having_VBG a_DT number_NN of_IN Pasteur_NNP Institutes_NNPS scattered_VBD over_IN the_DT country_NN it_PRP would_MD be_VB necessary_JJ to_TO have_VB only_RB a_DT Central_NNP Institute_NNP where_WRB the_DT vaccine_NN could_MD be_VB prepared_VBN and_CC sent_VBN to_TO other_JJ centres_NNS where_WRB treatment_NN could_MD be_VB carried_VBN out_RP ._.
The_DT expenses_NNS connected_VBN with_IN these_DT centres_NNS would_MD be_VB very_RB small_JJ ,_, long_JJ and_CC costly_JJ 1_CD Semple_NNP &_CC Matson_NNP :_: On_IN the_DT Preparation_NNP and_CC Keeping_NNP Properties_NNP of_IN Antityphoid_NNP Vaccines.5_NNP journeys_NNS would_MD be_VB avoided_VBN ,_, and_CC most_RBS important_JJ of_IN all_DT ,_, the_DT patients_NNS would_MD come_VB under_IN early_JJ treatment_NN ,_, and_CC a_DT treatment_NN free_JJ from_IN risks_NNS ._.
In_IN the_DT preparation_NN of_IN a_DT dead_JJ rabies_NNS vaccine_VBP it_PRP is_VBZ necessary_JJ to_TO know_VB what_WP are_VBP the_DT effects_NNS on_IN living_VBG virus_NN of_IN agents_NNS such_JJ as_IN heat_NN and_CC carbolic_NN acid_NN which_WDT could_MD be_VB used_VBN in_IN killing_VBG the_DT virus_NN ;_: and_CC in_IN testing_VBG the_DT rabicidal_NN properties_NNS of_IN the_DT serum_NN of_IN animals_NNS immunised_VBN with_IN a_DT rabies_NNS vaccine_NN it_PRP is_VBZ necessary_JJ to_TO know_VB what_WP are_VBP the_DT effects_NNS of_IN normal_JJ saline_JJ solution_NN (_( the_DT fluid_NN used_VBN to_TO prepare_VB dilutions_NNS )_) on_IN the_DT virus_NN dilutions_NNS used_VBN for_IN testing_VBG the_DT serum_NN ._.
The_DT experiments_NNS recorded_VBN in_IN Tables_NNP I_PRP to_TO IX_NNP answer_VB these_DT questions_NNS ._.
The_DT experiments_NNS recorded_VBN in_IN Series_NNP I_PRP to_TO V_NNP prove_VB that_DT animals_NNS ,_, such_JJ as_IN monkeys_NNS ,_, dogs_NNS ,_, and_CC rabbits_NNS ,_, can_MD be_VB highly_RB immunised_VBN with_IN a_DT dead_JJ rabies_NNS vaccine_VBP ,_, killed_VBN and_CC preserved_VBN in_IN carbolic_JJ acid_NN ._.
Other_JJ workers_NNS have_VBP also_RB obtained_VBN evidence_NN of_IN the_DT immunising_VBG properties_NNS of_IN dead_JJ rabies_NNS virus_NN ._.
Poor,1_NNP recording_VBG his_PRP$ own_JJ experiments_NNS with_IN heated_JJ virus_NN ,_, in_IN a_DT recent_JJ article_NN (_( September_NNP 1910_CD )_) mentions_NNS ,_, that_IN ,_, ``_`` Fermi_NNP as_IN the_DT result_NN of_IN his_PRP$ experiments_NNS recom-_NN mended_VBD the_DT use_NN of_IN dead_JJ virus_NN only_RB ;_: his_PRP$ plan_NN being_VBG to_TO kill_VB the_DT virus_NN with_IN carbolic_JJ acid_NN ,_, and_CC store_VBD the_DT emulsions_NNS for_IN future_JJ use._JJ ``_``
The_DT same_JJ author_NN also_RB mentions_VBZ that_IN ,_, ``_`` Otto_NNP Heller_NNP in_IN his_PRP$ work_NN on_IN protective_JJ inoculation_NN against_IN rabies_NNS (_( Jena_NNP ,_, 1906_CD )_) gives_VBZ the_DT experience_NN of_IN others_NNS in_IN the_DT use_NN of_IN virus_NN killed_VBN in_IN various_JJ ways_NNS ;_: e.g._NN ,_, heat_NN ,_, and_CC by_IN glycerine_NN ;_: and_CC his_PRP$ own_JJ experiments_NNS in_IN the_DT use_NN of_IN virus_NN killed_VBN by_IN grinding_VBG according_VBG to_TO the_DT method_NN of_IN McFadyen_NNP ._. ''_''
Heller_NNP used_VBD the_DT brains_NNS of_IN rabbits_NNS after_IN death_NN from_IN ``_`` fixed_VBN virus_NN ``_`` infection_NN ._.
1_CD Poor6_NNP CHAPTER_NNP II_NNP ._.
The_DT Effect_NNP of_IN Heat_NNP On_IN Rabies_NNP Virus_NNP ._.
TABLE_NN I_PRP ._.
It_PRP has_VBZ long_RB been_VBN known_VBN that_IN rabies_NNS virus_VBP is_VBZ easily_RB destroyed_VBN by_IN heat_NN ._.
This_DT is_VBZ a_DT fact_NN which_WDT has_VBZ been_VBN used_VBN to_TO prove_VB that_IN the_DT causal_JJ organism_NN of_IN rabies_NNS (_( what-_JJ ever_RB it_PRP may_MD eventually_RB turn_VB out_RP to_TO be_VB )_) can_MD not_RB be_VB a_DT spore-forming_JJ organism_NN ,_, for_IN we_PRP know_VBP that_IN all_DT spores_NNS require_VBP a_DT high_JJ temperature_NN before_IN they_PRP are_VBP destroyed_VBN ,_, and_CC that_IN many_JJ of_IN them_PRP require_VBP a_DT boiling_JJ temperature_NN before_IN they_PRP are_VBP even_RB injured_VBN ,_, and_CC a_DT few_JJ kinds_NNS require_VBP boiling_VBG for_IN one_CD or_CC two_CD hours_NNS before_IN their_PRP$ destruction_NN is_VBZ finally_RB accomplished_VBN ._.
The_DT very_RB fact_NN that_IN rabies_NNS virus_VBP is_VBZ so_RB sensitive_JJ to_TO heat_VB puts_VBZ the_DT causal_NN organism_NN out_IN of_IN the_DT category_NN of_IN spore-forming_JJ germs_NNS ._.
This_DT sensitiveness_NN to_TO heat_NN of_IN a_DT virus_NN about_IN the_DT nature_NN of_IN which_WDT we_PRP know_VBP so_RB little_JJ would_MD make_VB one_CD hesitate_NN before_IN using_VBG heat_NN as_IN an_DT agent_NN in_IN the_DT preparation_NN of_IN a_DT dead_JJ vaccine_NN ,_, a_DT vaccine_NN in_IN which_WDT an_DT extra-_NN cellular_JJ toxine_NN may_MD possibly_RB be_VB an_DT important_JJ factor_NN in_IN its_PRP$ immunising_NN properties_NNS ._.
Marie_NNP 1_CD states_NNS that_IN the_DT destruction_NN of_IN the_DT virus_NN begins_VBZ at_IN a_DT temperature_NN of_IN 45°C_CD ,_, and_CC that_IN 24_CD hours_NNS '_POS exposure_NN to_TO this_DT temperature_NN completes_VBZ its_PRP$ destruction_NN ._.
Marie_NNP also_RB mentions_VBZ the_DT following_JJ results_NNS of_IN the_DT effects_NNS of_IN heat_NN on_IN rabies_NNS virus_NNS obtained_VBN by_IN other_JJ workers_NNS :_: ``_`` On_IN peut_NN le_VBN stériliser_RBR par_JJ une_JJ chauffage_NN de_IN 5_CD minutes_NNS à_RB 48°_CD ,_, de_FW une_JJ heure_NN à_VBZ 50°_CD (_( Celli_NNP )_) ,_, de_FW quelques_FW minutes_NNS à_VBP 60°_CD (_( Roux_NNP )_) ,_, de_FW trente_FW minutes_NNS à_VBP 52.58°_CD (_( Högyes_NNP )_) ._. ''_''
It_PRP will_MD be_VB seen_VBN that_IN there_EX is_VBZ a_DT wide_JJ range_NN of_IN difference_NN in_IN the_DT examples_NNS given_VBN ,_, viz._FW ,_, from_IN 5_CD minutes_NNS at_IN 48°C_CD to_TO 1_CD hour_NN at_IN 50°C_CD (_( Celli_NNP )_) ;_: several_JJ minutes_NNS at_IN 60°C_CD (_( Roux_NNP )_) ;_: and_CC 30_CD minutes_NNS at_IN 52°_CD to_TO 58°C_CD (_( Högyes_NNP )_) ._.
The_DT results_NNS of_IN my_PRP$ own_JJ experiments_NNS on_IN this_DT point_NN are_VBP given_VBN in_IN Table_JJ 1_CD ._.
On_IN referring_VBG to_TO this_DT table_NN it_PRP will_MD be_VB seen_VBN that_IN a_DT 5_CD per_IN cent_NN ._.
emulsion_NN of_IN fixed_JJ virus_NN from_IN the_DT medulla_NN of_IN a_DT rabbit_NN is_VBZ destroyed_VBN when_WRB heated_VBN in_IN a_DT water_NN bath_NN at_IN a_DT temperature_NN of_IN 50°C_CD in_IN 15_CD minutes_NNS ,_, and_CC that_IN a_DT similar_JJ emulsion_NN is_VBZ not_RB even_RB injured_VBN in_IN 15_CD minutes_NNS at_IN a_DT temperature_NN of_IN 45°C_CD ._.
In_IN the_DT preparation_NN of_IN 5_CD per_IN cent_NN ._.
emulsions_NNS used_VBN in_IN the_DT experiments_NNS referred_VBD to_TO in_IN Table_NNP 1_CD ,_, one_CD gramme_NN was_VBD taken_VBN from_IN the_DT medulla_NN of_IN a_DT rabbit_NN soon_RB after_IN it_PRP had_VBD died_VBN from_IN ``_`` fixed_VBN virus_NN ``_`` rabies_NNS ;_: it_PRP was_VBD ground_VBN up_RP with_IN a_DT pestle_NN and_CC mortar_NN in_IN 20_CD c._NN sterile_JJ normal_JJ saline_JJ solution_NN ,_, and_CC then_RB passed_VBD through_IN a_DT fine_JJ wire_NN strainer_NN to_TO remove_VB any_DT rough_JJ particles_NNS of_IN fibrous_JJ tissue_NN ,_, etc_FW ._.
A_DT few_JJ c._NN c._NNS were_VBD then_RB transferred_VBN to_TO several_JJ sterile_JJ test_NN tubes_NN ,_, and_CC heated_VBN in_IN a_DT water_NN bath_NN at_IN the_DT temperatures_NNS ,_, and_CC for_IN the_DT times_NNS specified_VBN in_IN the_DT table_NN ._.
A_DT few_JJ minutes_NNS after_IN removal_NN from_IN the_DT water_NN bath_NN ,_, 0.2_CD c.c_NN ._.
was_VBD used_VBN to_TO inoculate_VB healthy_JJ full_JJ grown_VBN rabbits_NNS subdurally_RB ,_, with_IN the_DT results_NNS recorded_VBD in_IN Table_JJ 1_CD ._.
A_DT control_NN rabbit_NN 1_CD Marie7_NNP was_VBD also_RB inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
of_IN the_DT 5_CD per_IN cent_NN ._.
virus_NN emulsion_NN before_IN heating_NN ;_: and_CC this_DT rabbit_NN and_CC the_DT one_CD inoculated_VBN with_IN 0.2_CD c.c_NNS ._.
of_IN the_DT virus_NN after_IN heating_VBG at_IN 45°C_CD for_IN 15_CD minutes_NNS both_DT developed_JJ rabies_NNS on_IN the_DT seventh_JJ day_NN ._.
Five_CD other_JJ rabbits_NNS inoculated_VBN subdurally_RB with_IN a_DT similar_JJ amount_NN of_IN the_DT same_JJ virus_NN ,_, but_CC heated_VBD either_RB at_IN a_DT temperature_NN of_IN 55°C_CD or_CC 50°C_CD for_IN 30_CD or_CC 15_CD minutes_NNS ,_, remained_VBD well_RB ._.
The_DT results_NNS of_IN these_DT experiments_NNS show_VBP that_IN a_DT 5_CD per_IN cent_NN ._.
emulsion_NN of_IN fixed_JJ virus_NN in_IN normal_JJ saline_JJ solution_NN is_VBZ destroyed_VBN at_IN a_DT temperature_NN of_IN 50°C_CD in_IN 15_CD minutes_NNS ,_, but_CC not_RB at_IN a_DT temperature_NN of_IN 45°C_CD in_IN the_DT same_JJ time_NN ._.
TABLE_NN I_PRP ._.
Experiments_NNS to_TO test_VB the_DT effects_NNS of_IN heat_NN on_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' when_WRB emulsified_VBN in_IN normal_JJ saline_JJ solution_NN ._.
No_DT ._.
of_IN experi-_JJ ment_NN ._.
Percen-_JJ tage_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN normal_JJ saline_JJ solu-_JJ tion_NN used_VBN ._.
Time_NNP and_CC tempera-_JJ ture_NN at_IN which_WDT heated_VBD before_IN being_VBG used_VBN ._.
Animal_NNP inoculated_VBD ._.
Amount_NNP inocu-_NN laced_VBD ,_, and_CC method_NN of_IN in-_JJ oculation_NN ._.
Result_NN ._.
REMARKS_NNP ._.
Per_NNP cent_NN ._.
1_CD 5_CD 55°C_CD for_IN 30_CD minutes_NNS ._.
Rabbit_RB 0.2_CD c.c_NN ._.
subdural-_JJ ly_NN ._.
Remained_VBN well_RB ._.
2_CD 5_CD 55°C_CD for_IN 15_CD minutes_NNS ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
3_CD 5_CD 50°C_CD for_IN 30_CD minutes_NNS ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
4_CD 5_CD 50°C_CD for_IN 15_CD minutes_NNS ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
5_CD 5_CD 50°C_CD for_IN 15_CD minutes_NNS ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
6_CD 5_CD 45°C_CD for_IN 15_CD minutes_NNS ._.
Ditto_NNP ._.
Ditto_NNP ._.
Rabies_NNS ,_, 7th_CD day_NN ._.
7_CD 5_CD Not_RB heated_VBN Ditto_NNP ._.
Ditto_NNP ._.
Rabies_NNS ,_, 7th_CD day_NN ._.
Control_NNP ._.
A_DT 5_CD per_IN cent_NN ._.
dilution_NN of_IN fixed_JJ rabies_NNS virus_VBP in_IN normal_JJ saline_JJ solution_NN is_VBZ destroyed_VBN at_IN a_DT temperature_NN of_IN 50°C_CD in_IN 15_CD minutes_NNS ,_, but_CC not_RB in_IN the_DT same_JJ time_NN at_IN 45°C_CD ._.
C_$ 8_CD CHAPTER_NNP III_NNP ._.
The_DT Effect_NNP of_IN Carbolic_NNP Acid_NNP on_IN Rabies_NNP Virus_NNP ._.
The_DT fact_NN that_IN carbolic_JJ acid_NN destroys_VBZ rabies_NNS virus_NN has_VBZ never_RB been_VBN doubted_VBN ,_, but_CC in_IN order_NN to_TO kill_VB the_DT virus_NN for_IN the_DT purpose_NN of_IN making_VBG a_DT vaccine_NN ,_, the_DT dilution_NN of_IN carbo-_JJ lic_JJ acid_NN ,_, the_DT dilution_NN of_IN virus_NN to_TO use_VB ,_, the_DT temperature_NN to_TO which_WDT the_DT mixture_NN should_MD be_VB exposed_VBN and_CC the_DT time_NN limit_NN of_IN exposure_NN require_VBP careful_JJ consideration_NN ._.
The_DT less_JJR the_DT change_NN produced_VBN in_IN any_DT vaccine_NN used_VBN for_IN immunising_VBG purposes_NNS the_DT better_JJR ._.
This_DT is_VBZ a_DT principle_NN to_TO be_VB kept_VBN in_IN mind_NN when_WRB the_DT object_NN is_VBZ to_TO obtain_VB a_DT dead_JJ but_CC otherwise_RB unaltered_JJ and_CC efficient_JJ vaccine_NN ._.
It_PRP is_VBZ necessary_JJ that_IN the_DT active_JJ principle_NN and_CC original_JJ properties_NNS of_IN the_DT vaccine_NN ,_, once_RB it_PRP has_VBZ been_VBN rendered_VBN safe_JJ for_IN use_NN ,_, should_MD be_VB interfered_VBN with_IN as_RB little_JJ as_IN possible_JJ ,_, and_CC as_IN so_RB much_JJ depends_VBZ upon_IN the_DT immunising_NN properties_NNS of_IN a_DT rabies_NNS vaccine_VBP the_DT utmost_NN care_NN should_MD be_VB taken_VBN in_IN its_PRP$ preparation_NN ._.
In_IN order_NN to_TO place_VB the_DT subject_NN on_IN a_DT sound_NN footing_NN ,_, it_PRP was_VBD first_RB of_IN all_DT necessary_JJ to_TO experiment_VB with_IN various_JJ dilutions_NNS of_IN rabies_NNS virus_VBP to_TO which_WDT had_VBD been_VBN added_VBN various_JJ percentages_NNS of_IN pure_JJ carbolic_JJ acid_NN ,_, the_DT mixtures_NNS of_IN virus_NN and_CC carbolic_JJ acid_NN being_VBG kept_VBN for_IN variable_JJ periods_NNS either_CC at_IN room_NN temperature_NN ,_, or_CC a_DT temperature_NN of_IN 37°C_CD ._.
The_DT rabies_NNS virus_VBP used_VBN was_VBD ``_`` fixed_JJ virus_NN ``_`` taken_VBN fresh_JJ from_IN the_DT medulla_NN of_IN rabbits_NNS after_IN death_NN from_IN ``_`` fixed_VBN virus_NN ``_`` rabies_NNS ._.
A_DT portion_NN of_IN the_DT medulla_NN was_VBD removed_VBN a_DT few_JJ hours_NNS after_IN death_NN ,_, weighed_VBD ,_, then_RB ground_NN up_RP in_IN a_DT mortar_NN with_IN sterile_JJ normal_JJ saline_JJ solution_NN to_TO which_WDT had_VBD been_VBN added_VBN the_DT percentage_NN of_IN carbolic_JJ acid_NN to_TO be_VB tested_VBN ._.
The_DT emulsions_NNS were_VBD strained_VBN through_IN a_DT fine_JJ wire_NN strainer_NN ,_, and_CC filled_VBD into_IN bottles_NNS which_WDT were_VBD then_RB capped_VBN with_IN rubber_NN ,_, and_CC finally_RB exposed_VBN to_TO whatever_WDT temperature_NN it_PRP was_VBD desired_VBN to_TO test_VB ._.
By_IN this_DT means_VBZ it_PRP was_VBD easy_JJ to_TO obtain_VB any_DT dilution_NN of_IN virus_NN ,_, and_CC in_IN any_DT percentage_NN of_IN carbolic_JJ acid_NN desirable_JJ ;_: it_PRP was_VBD also_RB easy_JJ to_TO remove_VB a_DT sample_NN for_IN experimental_JJ purposes_NNS from_IN any_DT of_IN the_DT bottles_NNS by_IN puncturing_VBG the_DT rubber_NN cap_NN with_IN the_DT needle_NN of_IN a_DT syringe_NN and_CC withdrawing_VBG the_DT piston_NN ._.
The_DT test_NN applied_VBN in_IN all_DT cases_NNS was_VBD the_DT subdural_JJ inoculation_NN of_IN a_DT rabbit_NN with_IN 0.2_CD ,_, or_CC 0.25_CD c.c_NN ._.
of_IN the_DT carbolised_JJ virus_NN emulsion_NN ._.
Healthy_NNP full_JJ grown_NN animals_NNS were_VBD used_VBN in_IN all_DT these_DT experiments_NNS ._.
The_DT animals_NNS were_VBD anæsthetised_VBN ,_, trephined_VBN and_CC the_DT amount_NN specified_VBD injected_VBN under_IN the_DT dura-_JJ mater_NN ._.
The_DT first_JJ symptom_NN of_IN paralysis_NN was_VBD taken_VBN as_IN the_DT first_JJ sign_NN of_IN rabies_NNS ,_, although_IN in_IN some_DT cases_NNS it_PRP might_MD have_VB been_VBN possible_JJ to_TO arrive_VB at_IN a_DT diagnosis_NN by_IN taking_VBG into_IN consideration_NN other_JJ and_CC earlier_RBR symptoms_NNS ,_, such_JJ as_IN tremors_NNS of_IN the_DT head_NN ,_, when_WRB the_DT animals_NNS were_VBD disturbed_VBN ._.
TABLE_NNP II_NNP This_DT table_NN gives_VBZ the_DT results_NNS of_IN nine_CD experiments_NNS with_IN 1_CD per_IN cent_NN ._.
dilutions_NNS of_IN virus_NN in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN when_WRB the_DT mixture_NN 9_CD had_VBD been_VBN kept_VBN for_IN various_JJ periods_NNS up_RB to_TO 20_CD days_NNS at_IN room_NN temperature_NN ;_: also_RB the_DT result_NN of_IN one_CD experiment_NN with_IN 0.5_CD per_IN cent_NN ._.
rabies_NNS virus_VBP in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN when_WRB the_DT mixture_NN had_VBD been_VBN kept_VBN for_IN 24_CD hours_NNS at_IN room_NN temperature_NN ._.
It_PRP will_MD be_VB seen_VBN that_IN under_IN these_DT conditions_NNS 1_CD per_IN cent_NN ._.
rabies_NNS virus_VBP in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN retains_VBZ its_PRP$ virulence_NN unimpaired_VBD up_RB to_TO 12_CD days_NNS ,_, and_CC is_VBZ not_RB destroyed_VBN after_IN 20_CD days_NNS ,_, although_IN it_PRP had_VBD by_IN that_DT time_NN lost_VBD somewhat_RB in_IN virulence_NN ,_, as_IN shown_VBN by_IN a_DT 10_CD days_NNS '_POS incubation_NN period_NN when_WRB a_DT rabbit_NN was_VBD inoculated_VBN subdurally_RB ,_, instead_RB of_IN 7_CD days_NNS ,_, the_DT normal_JJ period_NN after_IN which_WDT a_DT rabbit_NN shows_VBZ symptoms_NNS of_IN paralysis_NN when_WRB inoculated_VBN subdurally_RB with_IN ``_`` fixed_JJ virus_NN ._. ''_''
In_IN experiment_JJ 9_CD it_PRP will_MD be_VB seen_VBN that_IN 0.5_CD per_IN cent_NN ._.
virus_NN in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN retains_VBZ its_PRP$ virulence_NN unimpaired_VBN at_IN room_NN temperature_NN for_IN 24_CD hours_NNS at_IN least_JJS ._.
TABLE_NNP II_NNP ._.
Experiments_NNS to_TO test_VB the_DT effect_NN of_IN carbolic_JJ acid_NN on_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' when_WRB kept_NN at_IN room_NN ,_, tem-_JJ perature_NN (_( about_IN 20º_CD C_NNP )_) ._.
No_DT ._.
of_IN experi-_JJ ment_NN ._.
Percentage_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN normal_JJ saline_JJ solu-_JJ tion_NN used_VBN ._.
Percen-_JJ tage_NN of_IN carbolic_JJ acid_NN added_VBD ._.
Time_NNP and_CC tem-_JJ perature_NN at_IN which_WDT kept_VBD be-_NN fore_NN being_VBG used_VBN ._.
Animal_JJ inocu-_NN lated_VBN ._.
Amount_NNP in-_JJ oculated_VBN ,_, and_CC method_NN of_IN inoculation_NN ._.
Result_NN ._.
REMARKS_NNP ._.
Per_NNP cent_NN ._.
Per_NNP cent_NN ._.
1_CD 1_CD 0.5_CD 24_CD hours_NNS ,_, room_NN temp._NN ,_, about_RB 20ºC_CD ._.
Rabbit_RB 0.2_CD c.c_NN ._.
sub-_JJ durally_RB ._.
Rabies_NNS ,_, 7th_CD day_NN ._.
2_CD 1_CD 0.5_CD 48_CD hours_NNS ,_, room_NN temp._NN ,_, about_RB 20ºC_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
3_CD 1_CD 0.5_CD 3_CD days_NNS ,_, room_NN temp._NN ,_, about_RB 20ºC_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
4_CD 1_CD 0.5_CD 4_CD days_NNS ,_, room_NN temp._NN ,_, about_RB 20ºC_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
5_CD 1_CD 0.5_CD 5_CD days_NNS ,_, room_NN temp._NN ,_, about_RB 20ºC_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
6_CD 1_CD 0.5_CD 10_CD days_NNS ,_, room_NN temp._NN ,_, about_RB 20ºC_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
7_CD 1_CD 0.5_CD 12_CD days_NNS ,_, room_NN temp._NN ,_, about_RB 20ºC_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
8_CD 1_CD 0.5_CD 20_CD days_NNS ,_, room_NN temp._NN ,_, about_RB 20ºC_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Rabies_NNS ,_, 10th_CD day_NN ._.
9_CD ½_JJ 0.5_CD 24_CD hours_NNS ,_, room_NN temp._NN ,_, about_RB 20ºC_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Rabies_NNS ,_, 7th_CD day_NN ._.
A_DT 1_CD per_IN cent_NN ._.
dilution_NN of_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' in_IN normal_JJ saline_JJ solution_NN can_MD survive_VB for_IN at_IN least_JJS 20_CD days_NNS in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN at_IN room_NN temperature_NN (_( about_IN 20ºC_CD )_) ._.
C_NNP 2_CD 10_CD TABLE_NNP III_NNP ._.
In_IN the_DT nine_CD experiments_NNS recorded_VBN in_IN this_DT table_NN ,_, seven_CD were_VBD carried_VBN out_IN with_IN 2_CD per_IN cent_NN ._.
dilutions_NNS of_IN virus_NN in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ;_: and_CC two_CD with_IN 4_CD per_IN cent_NN dilutions_NNS of_IN virus_NN in_IN 2_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ,_, when_WRB the_DT mixtures_NNS had_VBD been_VBN kept_VBN at_IN room_NN temperature_NN for_IN various_JJ periods_NNS ._.
The_DT results_NNS show_VBP that_IN a_DT 2_CD per_IN cent_NN ._.
dilution_NN of_IN virus_NN retains_VBZ its_PRP$ virulence_NN un-_JJ impaired_VBN in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN at_IN room_NN temperature_NN for_IN 3_CD days_NNS ,_, but_CC begins_VBZ to_TO lose_VB it_PRP after_IN 4_CD days_NNS ,_, and_CC is_VBZ killed_VBN in_IN 6_CD days_NNS ;_: and_CC that_IN a_DT 4_CD per_IN cent_NN ._.
dilution_NN of_IN virus_NN in_IN 2_CD per_IN cent_NN ._.
carbolic_JJ acid_NN is_VBZ killed_VBN in_IN 24_CD hours_NNS at_IN room_NN temperature_NN ._.
From_IN these_DT results_NNS it_PRP is_VBZ evident_JJ that_IN the_DT amount_NN of_IN carbolic_JJ acid_NN (_( 2_CD per_IN cent_NN ._. )_)
necessary_JJ to_TO kill_VB a_DT 4_CD per_IN cent_NN ._.
dilution_NN of_IN rabies_NNS virus_VBP in_IN 24_CD hours_NNS at_IN room_NN tempera-_JJ ture_NN is_VBZ too_RB large_JJ an_DT amount_NN to_TO be_VB retained_VBN in_IN a_DT vaccine_NN intended_VBN for_IN antirabic_JJ treatment_NN ;_: on_IN this_DT account_NN it_PRP was_VBD decided_VBN to_TO test_VB the_DT effects_NNS of_IN a_DT reduction_NN in_IN the_DT percentage_NN of_IN virus_NN ,_, and_CC not_RB to_TO increase_VB the_DT carbolic_JJ acid_NN beyond_IN 1_CD per_IN cent_NN ._.
(_( see_VB Table_NNP IV_NNP )_) ._.
TABLE_NNP III_NNP ._.
Experiments_NNS to_TO test_VB the_DT effect_NN of_IN carbolic_JJ acid_NN on_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' when_WRB kept_NN at_IN room_NN tem-_JJ perature_NN (_( about_IN 20°_CD C_NNP )_) ._.
No_DT ._.
of_IN experi-_JJ ment_NN ._.
Percentage_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN normal_JJ saline_JJ solu-_JJ tion_NN used_VBN ._.
Percen-_JJ tage_NN of_IN carbolic_JJ acid_NN added_VBD ._.
Time_NNP and_CC tem-_JJ perature_NN at_IN which_WDT kept_VBD before_IN being_VBG used_VBN ._.
Animal_JJ inocu-_NN lated_VBN ._.
Amount_NNP in-_JJ oculated_VBN and_CC method_NN of_IN inoculation_NN ._.
Result_NN ._.
REMARKS_NNP ._.
Per_NNP cent_NN ._.
Per_NNP cent_NN ._.
1_CD 2_CD 1_CD 24_CD hours_NNS ,_, room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Rabbit_RB 0.2_CD c.c._NN ,_, sub-_JJ durally_RB ._.
Rabies_NNS ,_, 7th_CD day_NN ._.
2_CD 2_CD 1_CD 48_CD hours_NNS ,_, room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
3_CD 2_CD 1_CD 3_CD days_NNS ,_, room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
4_CD 2_CD 1_CD 4_CD days_NNS ,_, room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Rabies_NNS ,_, 8th_CD day_NN ._.
5_CD 2_CD 1_CD 6_CD days_NNS ,_, room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Remained_VBN well_RB ._.
6_CD 2_CD 1_CD 9_CD days_NNS ,_, room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
7_CD 2_CD 1_CD 12_CD days_NNS ,_, room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
8_CD 4_CD 2_CD 24_CD hours_NNS ,_, room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
9_CD 4_CD 2_CD 24_CD hours_NNS ,_, room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
A_DT 2_CD per_IN cent_NN ._.
dilution_NN of_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' in_IN normal_JJ saline_JJ solution_NN can_MD survive_VB for_IN at_IN least_JJS 4_CD days_NNS ,_, but_CC not_RB for_IN 6_CD days_NNS in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN at_IN room_NN temperature_NN (_( about_IN 20°C_CD )_) ;_: but_CC a_DT 4_CD per_IN cent_NN ._.
is_VBZ destroyed_VBN in_IN 24_CD hours_NNS in_IN 2_CD per_IN cent_NN ._.
carbolic_JJ acid_NN at_IN room_NN temperature_NN ._.
11_CD TABLE_NNP IV_NNP ._.
This_DT presents_VBZ a_DT series_NN of_IN experiments_NNS carried_VBD out_IN with_IN 1_CD per_IN cent_NN ._.
dilutions_NNS of_IN rabies_NNS virus_VBP in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN when_WRB kept_NN at_IN room_NN temperature_NN for_IN various_JJ periods_NNS ._.
The_DT results_NNS of_IN this_DT series_NN show_NN that_IN a_DT 1_CD per_IN cent_NN ._.
dilution_NN of_IN virus_NN retains_VBZ its_PRP$ virulence_NN unimpaired_VBD for_IN 3_CD days_NNS in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN at_IN room_NN temperature_NN but_CC begins_VBZ to_TO lose_VB it_PRP after_IN 4_CD days_NNS ,_, and_CC is_VBZ killed_VBN in_IN 6_CD days_NNS ,_, therefore_RB a_DT vaccine_NN prepared_VBN by_IN this_DT method_NN would_MD require_VB 6_CD days_NNS ,_, and_CC it_PRP would_MD then_RB have_VB to_TO be_VB diluted_VBN with_IN an_DT equal_JJ volume_NN of_IN normal_JJ saline_JJ solution_NN so_RB as_IN to_TO reduce_VB the_DT amount_NN of_IN carbolic_JJ acid_NN to_TO a_DT workable_JJ percentage_NN for_IN antirabic_JJ treatment_NN ._.
This_DT would_MD give_VB 0.5_CD per_IN cent_NN ._.
dead_JJ rabies_NNS virus_VBP in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN after_IN waiting_VBG for_IN 6_CD days_NNS ._.
A_DT vaccine_NN prepared_VBN by_IN this_DT method_NN would_MD be_VB too_RB dilute_JJ for_IN efficient_JJ treatment_NN ,_, so_IN the_DT method_NN was_VBD discarded_VBN ._.
An_DT efficient_JJ rabies_NNS vaccine_NN should_MD contain_VB at_IN least_JJS 2_CD per_IN cent_NN ._.
rabies_NNS virus_NN ,_, and_CC not_RB more_JJR than_IN 0.5_CD per_IN cent_NN carbolic_NN acid_NN when_WRB administered_VBN to_TO patients_NNS ._.
To_TO obtain_VB such_JJ a_DT vaccine_NN by_IN killing_VBG the_DT virus_NN in_IN carbolic_JJ acid_NN at_IN room_NN temperature_NN in_IN 24_CD hours_NNS without_IN having_VBG to_TO add_VB too_RB large_JJ a_DT percentage_NN of_IN carbolic_JJ acid_NN in_IN the_DT first_JJ instance_NN would_MD be_VB impossible_JJ ._.
Marie1_NNP states_VBZ that_IN rabies_NNS virus_VBP in_IN 1_CD per_IN cent_NN ._.
dilutions_NNS is_VBZ not_RB destroyed_VBN in_IN 2.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN in_IN 24_CD hours_NNS at_IN room_NN temperature_NN ._.
TABLE_NNP IV_NNP ._.
Experiments_NNS to_TO test_VB the_DT effect_NN of_IN carbolic_JJ acid_NN on_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' when_WRB kept_NN at_IN room_NN tempera-_JJ ture_NN (_( about_IN 20°_CD C_NNP )_) ._.
No_DT ._.
of_IN experi-_JJ ment_NN ._.
Percentage_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN normal_JJ saline_JJ solu-_JJ tion_NN used_VBN ._.
Percen-_JJ tage_NN of_IN carbolic_JJ acid_NN added_VBD ._.
Time_NNP and_CC tem-_JJ perature_NN at_IN which_WDT kept_VBD before_IN being_VBG used_VBN ._.
Animal_JJ inocu-_NN lated_VBN ._.
Amount_NNP inoculated_VBD ,_, and_CC method_NN of_IN inoculation_NN ._.
Result_NN ._.
REMARKS_NNP ._.
Per_NNP cent_NN ._.
Per_NNP cent_NN ._.
1_CD 1_CD 1_CD 24_CD hours_NNS ,_, at_IN room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Rabbit_RB 0.2_CD c.c._NN ,_, sub-_JJ durally_RB ._.
Rabies_NNS ,_, 7th_CD day_NN ._.
2_CD 1_CD 1_CD 48_CD hours_NNS ,_, at_IN room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP Ditto_NNP ._.
3_CD 1_CD 1_CD 3_CD days_NNS ,_, at_IN room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP Ditto_NNP ._.
4_CD 1_CD 1_CD 4_CD days_NNS ,_, at_IN room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP Rabies_NNP ,_, 8th_CD day_NN ._.
5_CD 1_CD 1_CD 6_CD days_NNS ,_, at_IN room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP Remained_NNP well_RB ._.
6_CD 1_CD 1_CD 9_CD days_NNS ,_, at_IN room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP Ditto_NNP ._.
7_CD 1_CD 1_CD 12_CD days_NNS ,_, at_IN room_NN temperature_NN ,_, about_RB 20°C_CD ._.
Ditto_NNP ._.
Ditto_NNP Ditto_NNP ._.
A_DT 1_CD pe_NN cent_NN ._.
dilution_NN of_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' in_IN normal_JJ saline_JJ solution_NN can_MD survive_VB for_IN at_IN least_JJS 4_CD days_NNS ,_, but_CC not_RB for_IN 6_CD days_NNS in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN at_IN room_NN temperature_NN (_( about_IN 20°C_CD )_) ._.
1_CD Marie12_NNP TABLE_NNP V._NNP Owing_NNP to_TO the_DT results_NNS obtained_VBD from_IN the_DT experiments_NNS given_VBN in_IN Tables_NNP II_NNP ,_, III_NNP ,_, and_CC IV_NNP with_IN dilutions_NNS of_IN rabies_NNS virus_VBP in_IN various_JJ percentages_NNS of_IN carbolic_JJ acid_NN ,_, it_PRP was_VBD necessary_JJ to_TO try_VB the_DT killing_VBG effects_NNS of_IN carbolic_JJ acid_NN on_IN rabies_NNS virus_VBP at_IN a_DT temperature_NN of_IN 37ºC_CD ._.
It_PRP is_VBZ a_DT well_RB known_VBN fact_NN that_IN rabies_VBZ virus_NN can_MD survive_VB for_IN a_DT prolonged_JJ period_NN in_IN glycerine_NN at_IN room_NN temperature_NN ,_, but_CC is_VBZ quickly_RB killed_VBN in_IN gly-_JJ cerine_NN at_IN a_DT temperature_NN of_IN 37ºC_CD ._.
It_PRP will_MD be_VB seen_VBN from_IN the_DT experiments_NNS which_WDT follow_VBP that_IN the_DT killing_VBG power_NN of_IN carbolic_JJ acid_NN on_IN rabies_NNS virus_NN is_VBZ also_RB increased_VBN at_IN a_DT tem-_JJ perature_NN of_IN 37ºC_CD ._.
In_IN this_DT series_NN of_IN twelve_JJ experiments_NNS ,_, four_CD were_VBD carried_VBN out_IN with_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN added_VBD to_TO 2_CD per_IN cent._NN ,_, 1_CD per_IN cent._NN ,_, and_CC 0.5_CD per_IN cent_NN ._.
dilu-_JJ tions_NNS of_IN rabies_NNS virus_VBP ;_: and_CC eight_CD with_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN added_VBD to_TO 1_CD per_IN cent._NN ,_, 2_CD per_IN cent._NN ,_, and_CC 4_CD per_IN cent_NN ._.
dilutions_NNS of_IN rabies_NNS virus_NNS ._.
All_PDT these_DT carbolised_VBN emul-_NN sions_NNS of_IN virus_NN were_VBD kept_VBN for_IN 24_CD hours_NNS at_IN a_DT temperature_NN of_IN 37ºC_CD before_IN being_VBG used_VBN to_TO inoculate_VB rabbits_NNS subdurally_RB with_IN 0.25_CD c.c_NNS ._.
On_IN referring_VBG to_TO the_DT table_NN it_PRP will_MD be_VB seen_VBN that_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN does_VBZ not_RB kill_VB rabies_NNS virus_VBP in_IN 24_CD hours_NNS at_IN a_DT temperature_NN of_IN 37ºC_CD even_RB when_WRB the_DT virus_NN is_VBZ tested_VBN in_IN 0.5_CD per_IN cent_NN ._.
dilutions_NNS ;_: and_CC that_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN kills_VBZ a_DT 4_CD per_IN cent_NN ._.
dilu-_JJ tion_NN of_IN rabies_NNS virus_VBP in_IN 24_CD hours_NNS at_IN this_DT temperature_NN (_( 37ºC_CD )_) ._.
The_DT result_NN of_IN this_DT last_JJ experiment_NN showed_VBD that_IN it_PRP was_VBD reasonable_JJ to_TO expect_VB that_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN at_IN a_DT temperature_NN of_IN 37ºC_CD would_MD probably_RB kill_VB stronger_JJR preparations_NNS of_IN the_DT virus_NN ,_, and_CC as_IN this_DT point_NN was_VBD of_IN practical_JJ importance_NN in_IN the_DT preparation_NN of_IN a_DT stronger_JJR vaccine_NN it_PRP was_VBD necessary_JJ to_TO investigate_VB still_RB further_RB the_DT killing_VBG properties_NNS of_IN carbolic_JJ acid_NN at_IN a_DT temperature_NN of_IN 37ºC_CD ._.
TABLE_NNP V._NNP Experiments_NNP to_TO test_VB the_DT effect_NN of_IN carbolic_JJ acid_NN on_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' when_WRB kept_NN at_IN a_DT tem-_JJ perature_NN of_IN 37ºC_CD for_IN 24_CD hours_NNS ._.
No_DT ._.
of_IN experi-_JJ ment_NN ._.
Percentage_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN normal_JJ saline_JJ solu-_JJ tion_NN used_VBN ._.
Percen-_JJ tage_NN of_IN carbolic_JJ acid_NN added_VBD ._.
Time_NNP and_CC temperature_NN at_IN which_WDT kept_VBD before_IN being_VBG used_VBN ._.
Animal_JJ inocu-_NN lated_VBN ._.
Amount_NNP inoculated_VBD ,_, and_CC method_NN of_IN inocu-_JJ lation_NN ._.
Result_NN ._.
REMARKS_NNP ._.
Per_NNP cent_NN ._.
Per_NNP cent_NN ._.
1_CD 2_CD 0.5_CD 24_CD hours_NNS at_IN 37°C_CD Rabbit_NNP 0.25_CD c.c_NN ._.
Rabies_NNS ,_, 9th_CD day_NN ._.
2_CD 2_CD 0.5_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
3_CD 1_CD 0.5_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Rabies_NNS ,_, 7th_CD day_NN ._.
4_CD ½_JJ 0.5_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Rabies_NNS ,_, 8th_CD day_NN ._.
5_CD 1_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Remained_VBN well_RB ._.
6_CD 2_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
7_CD 4_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
8_CD 4_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
9_CD 4_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
10_CD 4_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
11_CD 4_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
12_CD 4_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
A_DT 2_CD per_IN cent._NN ,_, 1_CD per_IN cent._NN ,_, or_CC ½_VB per_IN cent_NN ._.
dilution_NN of_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN is_VBZ not_RB destroyed_VBN in_IN 24_CD hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD ;_: but_CC a_DT 4_CD per_IN cent_NN ._.
dilution_NN in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN is_VBZ destroyed_VBN in_IN 24_CD hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD ._.
13_CD TABLE_NNP VI_NNP ._.
In_IN the_DT series_NN of_IN six_CD experiments_NNS recorded_VBN in_IN this_DT table_NN the_DT rabicidal_NN properties_NNS of_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN at_IN a_DT temperature_NN of_IN 37°C_CD were_VBD tested_VBN on_IN 8_CD per_IN cent_NN ._.
dilutions_NNS of_IN rabies_NNS virus_NNS ,_, with_IN the_DT result_NN that_IN in_IN every_DT instance_NN the_DT virus_NN was_VBD killed_VBN in_IN 24_CD hours_NNS ._.
A_DT vaccine_NN prepared_VBN by_IN this_DT method_NN and_CC then_RB diluted_VBD with_IN an_DT equal_JJ volume_NN of_IN sterile_JJ normal_JJ saline_JJ solution_NN becomes_VBZ 4_CD per_IN cent_NN ._.
rabies_NNS virus_VBP in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN ;_: a_DT very_RB suitable_JJ strength_NN of_IN virus_NN for_IN antirabic_JJ treatment_NN ,_, containing_VBG sufficient_JJ carbolic_JJ acid_NN to_TO prevent_VB any_DT chance_NN of_IN subsequent_JJ contamination_NN when_WRB stored_VBN for_IN use_NN after_IN being_VBG made_VBN up_RP ._.
The_DT safety_NN of_IN such_JJ a_DT vaccine_NN is_VBZ beyond_IN dispute_NN ;_: so_CC the_DT next_JJ point_NN to_TO decide_VB was_VBD ,_, is_VBZ it_PRP efficient_JJ in_IN conferring_VBG immunity_NN against_IN the_DT subdural_JJ inoculation_NN of_IN lethal_JJ doses_NNS of_IN living_NN rabies_NNS virus_VBP in_IN animals_NNS ,_, such_JJ as_IN monkeys_NNS ,_, dogs_NNS ,_, and_CC rabbits_NNS ?_.
The_DT immunising_NN experiments_NNS recorded_VBD further_RBR on_IN furnish_JJ the_DT answer_NN to_TO this_DT question_NN ._.
TABLE_NNP VI_NNP ._.
Experiments_NNS to_TO test_VB the_DT effect_NN of_IN carbolic_JJ acid_NN on_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' when_WRB kept_NN at_IN a_DT tem-_JJ perature_NN of_IN 37°C_CD for_IN 24_CD hours_NNS ._.
No_DT ._.
of_IN experi-_JJ ment_NN ._.
Percentage_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN normal_JJ saline_JJ solution_NN used_VBN ._.
Percen-_JJ tage_NN of_IN carbolic_JJ acid_NN added_VBD ._.
Time_NNP and_CC temperature_NN at_IN which_WDT kept_VBD before_IN being_VBG used_VBN ._.
Animal_JJ inocu-_NN lated_VBN ._.
Amount_NNP inoculated_VBD ,_, and_CC method_NN of_IN inocu-_JJ lation_NN ._.
Result_NN ._.
REMARKS_NNP ._.
Per_NNP cent_NN ._.
Per_NNP cent_NN ._.
1_CD 8_CD 1_CD 24_CD hours_NNS at_IN 37°C_CD ._.
Rabbit_RB 0.25_CD c.c._NN ,_, subdurally_RB ._.
Remained_VBN well_RB ._.
2_CD 8_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
3_CD 8_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
4_CD 8_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
5_CD 8_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
6_CD 8_CD 1_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
8_CD per_IN cent_NN ._.
dilutions_NNS of_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' in_IN normal_JJ saline_JJ solution_NN are_VBP killed_VBN in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN in_IN 24_CD hours_NNS at_IN a_DT tem-_JJ perature_NN of_IN 37°_CD C._NNP 14_CD CHAPTER_NNP IV_NNP ._.
The_DT Effect_NNP of_IN Normal_NNP Saline_NNP Solution_NNP on_IN Rabies_NNP Virus_NNP ._.
Before_IN proceeding_VBG to_TO demonstrate_VB the_DT immunising_NN properties_NNS of_IN a_DT 4_CD per_IN cent_NN ._.
dilution_NN of_IN dead_JJ rabies_NNS virus_VBP in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ,_, it_PRP is_VBZ necessary_JJ to_TO prove_VB the_DT effect_NN of_IN normal_JJ saline_JJ solution_NN on_IN rabies_NNS virus_VBP at_IN room_NN temperature_NN ,_, and_CC also_RB at_IN a_DT temperature_NN of_IN 37°C_CD as_IN some_DT of_IN the_DT tests_NNS of_IN immunity_NN (_( such_JJ as_IN the_DT rabicidal_NN properties_NNS of_IN the_DT serum_NN )_) applied_VBD to_TO the_DT animals_NNS treated_VBD with_IN dead_JJ rabies_NNS virus_VBP depend_VBP upon_IN this_DT point_NN ,_, viz._NN ,_, whether_IN dilutions_NNS of_IN rabies_NNS virus_NNS are_VBP or_CC are_VBP not_RB quickly_RB killed_VBN in_IN normal_JJ saline_JJ solution_NN ._.
The_DT experiments_NNS of_IN Lamb_NNP and_CC McKendrick1_NNP on_IN the_DT effect_NN of_IN incubation_NN at_IN 37°C_CD on_IN 1_CD in_IN 200_CD ,_, and_CC 1_CD in_IN 1,600_CD dilutions_NNS of_IN rabies_NNS virus_VBP in_IN normal_JJ saline_JJ soultion_NN for_IN various_JJ periods_NNS up_RB to_TO 24_CD hours_NNS show_VBP that_IN the_DT virus_NN is_VBZ partially_RB destroyed_VBN after_IN from_IN 2_CD to_TO 4_CD hours_NNS ,_, and_CC completely_RB destroyed_VBN after_IN 24_CD hours_NNS ._.
My_PRP$ own_JJ experiments_NNS on_IN this_DT point_NN failed_VBD to_TO confirm_VB those_DT of_IN Lamb_NNP and_CC McKendrick_NNP (_( see_VB Table_NNP IX_NNP )_) ._.
1.15_CD TABLE_NNP VII_NNP ._.
Experiments_NNS to_TO test_VB the_DT effect_NN of_IN normal_JJ saline_JJ solution_NN on_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' when_WRB kept_NN at_IN room_NN temperature_NN (_( about_IN 20°C_CD )_) ._.
No_DT ._.
of_IN experi-_JJ ment_NN ._.
Percentage_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN normal_JJ saline_JJ solution_NN used_VBN ._.
Time_NNP and_CC temperature_NN at_IN which_WDT kept_VBD before_IN being_VBG used_VBN ._.
Animal_NNP inoculated_VBD ._.
Amount_NNP inoculated_VBD ,_, and_CC method_NN of_IN inoculation_NN ._.
Result_NN ._.
REMARKS_NNP ._.
Per_NNP cent_NN ._.
1_CD 1_CD 24_CD hours_NNS ,_, room_NN tem-_JJ perature_NN ,_, about_RB 20°_CD C._NNP Rabbit_NNP 0.2_CD c.c_NN ._.
sub-_JJ durally_RB ._.
Rabies_NNS ,_, 7th_CD day_NN ._.
2_CD 1_CD 48_CD hours_NNS ,_, room_NN tem-_JJ perature_NN ,_, about_RB 20°_CD C._NNP Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
3_CD 1_CD 3_CD days_NNS ,_, room_NN tempera-_JJ ture_NN ,_, about_RB 20°_CD C._NNP Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
4_CD 1_CD 4_CD days_NNS ,_, room_NN tempera-_JJ ture_NN ,_, about_RB 20°_CD C._NNP Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
5_CD 1_CD 11_CD days_NNS ,_, room_NN tem-_JJ perature_NN ,_, about_RB 20°_CD C._NNP Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
6_CD 1_CD 15_CD days_NNS ,_, room_NN tem-_JJ perature_NN ,_, about_RB 20°_CD C._NNP Ditto_NNP ._.
Ditto_NNP ._.
Rabies_NNS ,_, 9th_CD day_NN ._.
A_DT 1_CD per_IN cent_NN ._.
dilution_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN normal_JJ saline_JJ solution_NN is_VBZ not_RB destroyed_VBN in_IN 15_CD days_NNS when_WRB kept_NN at_IN room_NN temperature_NN (_( about_IN 20º_CD C_NNP )_) ._.
2.16_CD It_PRP is_VBZ evident_JJ from_IN these_DT results_NNS that_IN a_DT 1_CD in_IN 200_CD dilution_NN of_IN rabies_NNS virus_VBP in_IN normal_JJ saline_JJ solution_NN is_VBZ not_RB destroyed_VBN in_IN 24_CD hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD ;_: and_CC that_IN it_PRP can_MD still_RB further_RBR survive_VBP the_DT effects_NNS of_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN for_IN another_DT 24_CD hours_NNS at_IN room_NN temperature_NN ._.
TABLE_NNP VIII_NNP ._.
Experiments_NNS to_TO test_VB the_DT effect_NN of_IN normal_JJ saline_JJ solution_NN on_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' when_WRB kept_VBD for_IN 24_CD hours_NNS at_IN 37°C_CD ,_, followed_VBN by_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN at_IN room_NN temperature_NN for_IN another_DT 24_CD hours_NNS ._.
No_DT ._.
of_IN experi-_JJ ment_NN ._.
Dilution_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN normal_JJ saline_JJ solution_NN ._.
Treatment_NN to_TO which_WDT it_PRP was_VBD subjected_VBN before_IN being_VBG used_VBN ._.
Animal_NNP inoculated_VBD ._.
Amount_NNP inoculated_VBD ,_, and_CC method_NN of_IN inoculation_NN ._.
Result_NN ._.
REMARKS_NNP ._.
1_CD 1_CD in_IN 100_CD 24_CD hours_NNS at_IN 37°C_CD ,_, then_RB 24_CD hours_NNS at_IN room_NN temperature_NN ,_, and_CC finally_RB 24_CD hours_NNS in_IN ½_NNP per_IN cent_NN ._.
carbolic_JJ acid_NN at_IN room_NN tem-_JJ perature_NN ._.
Rabbit_RB 0.3_CD c.c_NN ._.
sub-_JJ durally_RB ._.
Rabies_NNS ,_, 7th_CD day_NN ._.
2_CD 1_CD in_IN 200_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Rabies_NNS ,_, 8th_CD day_NN ._.
3_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
4_CD Ditto_NNP ._.
24_CD hours_NNS at_IN 37°C_CD Ditto_NNP ._.
Ditto_NNP ._.
Rabies_NNS ,_, 7th_CD day_NN ._.
Control_NNP ._.
1_CD per_IN cent_NN ._.
and_CC ½_NNP per_IN cent_NN ._.
dilutions_NNS of_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' in_IN normal_JJ saline_JJ solution_NN are_VBP not_RB destroyed_VBN when_WRB kept_NN for_IN 24_CD hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD ,_, then_RB for_IN 24_CD hours_NNS at_IN room_NN temperature_NN ,_, followed_VBN by_IN another_DT 24_CD hours_NNS in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN at_IN room_NN temperature_NN ._.
TABLE_NNP IX_NNP ._.
The_DT results_NNS recorded_VBD in_IN Table_NNP VIII_NNP clearly_RB indicate_VBP that_IN a_DT temperature_NN of_IN 37°C_CD ._.
for_IN 24_CD hours_NNS has_VBZ no_DT effect_NN in_IN diminishing_VBG the_DT virulence_NN of_IN either_CC a_DT 1_CD per_IN cent_NN ._.
or_CC a_DT 0.5_CD per_IN cent_NN ._.
dilution_NN of_IN rabies_NNS virus_VBP in_IN normal_JJ saline_JJ solution_NN ._.
In_IN order_NN to_TO leave_VB no_DT possible_JJ doubt_NN on_IN this_DT point_NN it_PRP was_VBD decided_VBN to_TO carry_VB out_RP similar_JJ experiments_NNS ,_, but_CC with_IN higher_JJR dilutions_NNS kept_VBD for_IN various_JJ periods_NNS up_RB to_TO 24_CD hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD ._.
Two_CD dilutions_NNS in_IN normal_JJ saline_JJ solution_NN were_VBD prepared_VBN from_IN the_DT medulla_NN of_IN a_DT rabbit_NN a_DT few_JJ hours_NNS after_IN the_DT animal_NN had_VBD died_VBN from_IN fixed_VBN virus17_NN similar_JJ series_NN with_IN 0.3_CD c.c_NNS ._.
from_IN the_DT 1_CD in_IN 1,600_CD dilution_NN also_RB kept_VBD for_IN 1_CD ,_, 2_CD ,_, 4_CD ,_, and_CC 24_CD hours_NNS in_IN the_DT incubator_NN at_IN 37°C_CD ._.
The_DT rabbits_NNS inoculated_VBN with_IN the_DT 1_CD in_IN 200_CD virus_NN kept_VBD for_IN 1_CD ,_, 2_CD ,_, 4_CD ,_, and_CC 24_CD hours_NNS at_IN 37°C_CD all_DT developed_VBN rabies_NNS on_IN the_DT 7th_JJ day_NN ;_: and_CC those_DT inoculated_VBN with_IN the_DT 1_CD in_IN 1,600_CD virus_NN kept_VBD for_IN 1_CD ,_, 2_CD ,_, and_CC 4_CD hours_NNS also_RB developed_VBD rabies_NNS on_IN the_DT 7th_JJ day_NN ._.
Two_CD rabbits_NNS inoculated_VBN with_IN the_DT 1_CD in_IN 1,600_CD virus_NN kept_VBD for_IN 24_CD hours_NNS at_IN 37°C_CD developed_JJ rabies_NNS ,_, one_CD on_IN the_DT 10th_JJ day_NN ,_, and_CC the_DT other_JJ on_IN the_DT 11th_CD day_NN ._.
The_DT results_NNS of_IN this_DT series_NN of_IN experiments_NNS prove_VBP that_IN dilutions_NNS of_IN 1_CD in_IN 200_CD rabies_NNS virus_VBP in_IN normal_JJ saline_JJ solution_NN are_VBP not_RB destroyed_VBN in_IN 24_CD hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD ;_: and_CC that_DT dilution_NN of_IN 1_CD in_IN 1,600_CD loses_NNS nothing_NN of_IN its_PRP$ virulence_NN when_WRB kept_NN for_IN 4_CD hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD ,_, but_CC has_VBZ lost_VBN a_DT little_JJ of_IN its_PRP$ virulence_NN although_IN not_RB destroyed_VBN at_IN the_DT end_NN of_IN 24_CD hours_NNS ._.
TABLE_NNP IX_NNP ._.
Experiments_NNS to_TO test_VB the_DT effect_NN of_IN normal_JJ saline_JJ solution_NN on_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' when_WRB kept_NN at_IN a_DT temperature_NN of_IN 37°C_CD for_IN various_JJ periods_NNS up_RB to_TO 24_CD hours_NNS ._.
No_DT ._.
of_IN experi-_JJ ment_NN ._.
Percen-_JJ tage_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN normal_JJ saline_JJ solution_NN ._.
Time_NNP and_CC temperature_NN at_IN which_WDT kept_VBD before_IN being_VBG used_VBN ._.
Animal_NNP inoculated_VBD ._.
Amount_NNP inoculated_VBD ,_, and_CC method_NN of_IN inoculation_NN ._.
Result_NN ._.
REMARKS_NNP ._.
1_CD 1_CD in_IN 200_CD Used_VBD when_WRB made_VBN up_RP Rabbit_NNP 0.2_CD c.c_NN ._.
sub-_JJ durally_RB ._.
Rabies_NNS ,_, 7th_CD day_NN ._.
Controls_NNS of_IN experi-_JJ ments_NNS 3_CD ,_, 4_CD ,_, 5_CD and_CC 6_CD ._.
2_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
0.3_CD c.c_NN ._.
sub-_JJ durally_RB ._.
Ditto_NNP ._.
3_CD Ditto_NNP ._.
1_CD hour_NN at_IN 37°C_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
4_CD Ditto_NNP ._.
2_CD hours_NNS at_IN 37°C_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
5_CD Ditto_NNP ._.
4_CD hours_NNS at_IN 37°C_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
6_CD Ditto_NNP ._.
24_CD hours_NNS at_IN 37°C_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
7_CD 1_CD in_IN 1,600_CD Used_VBD when_WRB made_VBN up_RP Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Control_NN of_IN experi-_JJ ments_NNS 8_CD ,_, 9_CD ,_, 10_CD ,_, 11_CD and_CC 12_CD ._.
8_CD Ditto_NNP ._.
1_CD hour_NN at_IN 37°C_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
9_CD Ditto_NNP ._.
2_CD hours_NNS at_IN 37°C_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
10_CD Ditto_NNP ._.
4_CD hours_NNS at_IN 37°C_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
11_CD Ditto_NNP ._.
24_CD hours_NNS at_IN 37°C_CD Ditto_NNP ._.
Ditto_NNP ._.
Rabies_NNS ,_, 11th_CD day_NN ._.
12_CD Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Rabies_NNS ,_, 10th_CD day_NN ._.
A_DT 1_CD in_IN 200_CD ,_, and_CC a_DT 1_CD in_IN 1,600_CD dilutions_NNS of_IN ``_`` fixed_JJ rabies_NNS virus_NN ''_'' in_IN normal_JJ saline_JJ solution_NN are_VBP not_RB destroyed_VBN when_WRB kept_NN at_IN a_DT tempera-_JJ ture_NN of_IN 37°C_CD for_IN 24_CD hours_NNS ._.
D_NNP 2_CD 18_CD CHAPTER_NN V._NNP The_DT Immunisation_NNP of_IN Animals_NNP with_IN Rabies_NNP Virus_NNP killed_VBN by_IN Carbolic_NNP Acid_NNP ,_, and_CC their_PRP$ Subsequent_JJ Resistance_NN to_TO the_DT Subdural_NNP Inocula-_NNP tion_NN of_IN Lethal_NNP Doses_NNP of_IN ``_`` Street_NNP Virus_NNP ,_, ''_'' and_CC also_RB of_IN ``_`` Fixed_NNP Virus_NNP ._. ''_''
The_DT vaccines_NNS used_VBN in_IN these_DT immunising_VBG experiments_NNS were_VBD prepared_VBN from_IN the_DT brain_NN and_CC medulla_NN of_IN rabbits_NNS dead_VBP from_IN ``_`` fixed_VBN virus_NN ``_`` rabies_NNS ._.
The_DT dilutions_NNS of_IN living_NN virus_NN used_VBN to_TO test_VB for_IN immunity_NN were_VBD prepared_VBN from_IN the_DT medulla_NN ._.
In_IN no_DT case_NN was_VBD a_DT vaccine_NN or_CC a_DT test_NN virus_NN prepared_VBN from_IN the_DT spinal_JJ cord_NN ,_, as_IN the_DT cord_NN contains_VBZ less_RBR virus_NN than_IN the_DT brain_NN and_CC medulla_NN ,_, and_CC besides_IN the_DT virus_NN in_IN the_DT cord_NN may_MD not_RB be_VB so_RB evenly_RB distributed_VBN as_IN it_PRP is_VBZ in_IN the_DT brain_NN and_CC medulla_NN ._.
Nitsch_NNP 1_CD has_VBZ shown_VBN that_IN in_IN ``_`` fixed_JJ virus_NN ``_`` rabies_VBZ the_DT brain_NN and_CC medulla_NN are_VBP more_RBR virulent_JJ (_( i.e._FW ,_, contain_VBP more_JJR virus_NN )_) than_IN the_DT spinal_JJ cord_NN ,_, and_CC this_DT has_VBZ been_VBN confirmed_VBN by_IN other_JJ workers_NNS ._.
In_IN three_CD of_IN the_DT four_CD series_NN of_IN experiments_NNS here_RB recorded_VBN ,_, the_DT virus_NN was_VBD killed_VBN by_IN exposing_VBG 8_CD per_IN cent_NN ._.
dilutions_NNS in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN to_TO a_DT temperature_NN of_IN 37°C_CD for_IN 24_CD hours_NNS ._.
An_DT equal_JJ volume_NN of_IN sterile_JJ normal_JJ saline_JJ solution_NN was_VBD then_RB added_VBN ,_, and_CC the_DT mixture_NN put_VBD aside_RB until_IN it_PRP was_VBD required_VBN for_IN use_NN ._.
This_DT gave_VBD a_DT 4_CD per_IN cent_NN ._.
dead_JJ virus_NN in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ._.
In_IN one_CD series_NN of_IN experiments_NNS (_( Table_JJ IV_NNP ,_, 4th_CD series_NN )_) on_IN rabbits_NNS ,_, the_DT virus_NN used_VBN was_VBD a_DT 2_CD per_IN cent_NN ._.
dilution_NN in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ,_, and_CC killed_VBN in_IN the_DT same_JJ way_NN as_IN described_VBN above_IN ,_, viz._NN ,_, by_IN exposing_VBG a_DT 4_CD per_IN cent_NN ,_, dilution_NN of_IN fixed_JJ virus_NN in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN to_TO a_DT temperature_NN of_IN 37°C_CD for_IN 24_CD hours_NNS and_CC then_RB diluting_VBG with_IN an_DT equal_JJ volume_NN of_IN sterile_JJ normal_JJ saline_JJ solution_NN ._.
The_DT animals_NNS subjected_VBD to_TO treatment_NN were_VBD monkeys_NNS ,_, dogs_NNS ,_, and_CC rabbits_NNS ._.
In_IN all_DT cases_NNS the_DT vaccine_NN was_VBD injected_VBN hypodermically_RB on_IN the_DT sides_NNS of_IN the_DT abdomen_NNS ,_, and_CC as_RB far_RB as_IN possible_JJ a_DT fresh_JJ site_NN was_VBD selected_VBN each_DT time_NN ._.
One_CD dose_NN of_IN vaccine_NN was_VBD given_VBN daily,19_NN which_WDT has_VBZ been_VBN subjected_VBN to_TO this_DT treatment_NN is_VBZ invariably_RB killed_VBN ._.
This_DT opinion_NN is_VBZ based_VBN on_IN the_DT results_NNS of_IN some_DT 20_CD experiments_NNS ._.
The_DT test_NN of_IN immunity_NN applied_VBN to_TO the_DT animals_NNS after_IN treatment_NN consisted_VBN in_IN the_DT subdural_JJ inoculation_NN of_IN living_NN virulent_NN rabies_NNS virus_VBP ;_: and_CC previous_JJ to_TO this_DT the_DT serum_NN was_VBD tested_VBN for_IN its_PRP$ rabicidal_NN properties_NNS ._.
The_DT results_NNS of_IN these_DT experiments_NNS are_VBP given_VBN in_IN the_DT tables_NNS which_WDT follow_VBP ._.
It_PRP is_VBZ necessary_JJ to_TO explain_VB that_IN the_DT subdural_JJ inoculation_NN of_IN living_NN rabies_NNS virus_VBP is_VBZ a_DT very_RB severe_JJ test_NN of_IN immunity_NN ,_, and_CC that_IN it_PRP requires_VBZ a_DT very_RB high_JJ degree_NN of_IN immunity_NN to_TO withstand_VB this_DT test_NN ._.
In_IN the_DT practical_JJ application_NN of_IN antirabic_JJ treatment_NN ,_, it_PRP is_VBZ not_RB necessary_JJ to_TO confer_VB such_JJ a_DT high_JJ degree_NN of_IN immunity_NN in_IN order_NN to_TO prevent_VB infec-_JJ tion_NN from_IN the_DT bites_NNS of_IN rabid_NN animals_NNS ._.
I_PRP am_VBP sure_JJ that_IN very_RB few_JJ (_( if_IN any_DT )_) patients_NNS after_IN undergoing_VBG an_DT ordinary_JJ course_NN of_IN antirabic_JJ treatment_NN at_IN a_DT Pasteur_NNP Institute_NNP would_MD survive_VB the_DT subdural_JJ inoculation_NN of_IN living_NN rabies_NNS virus_VBP ,_, although_IN they_PRP had_VBD acquired_VBN sufficient_JJ immunity_NN to_TO prevent_VB the_DT onset_NN of_IN hydrophobia_NN after_IN being_VBG bitten_VBN by_IN rabid_NN animals_NNS ._.
The_DT fact_NN that_IN it_PRP is_VBZ possible_JJ to_TO immunise_VB even_RB a_DT small_JJ percentage_NN of_IN animals_NNS treated_VBN with_IN a_DT rabies_NNS vaccine_NN against_IN the_DT subsequent_JJ subdural_JJ inoculation_NN of_IN a_DT living_NN rabies_NNS virus_VBP is_VBZ sufficient_JJ proof_NN that_IN such_PDT a_DT vaccine_NN is_VBZ efficient_JJ ._.
It_PRP is_VBZ a_DT well_RB known_VBN fact_NN that_IN no_DT matter_NN what_WP method_VBZ we_PRP adopt_VBP in_IN immunising_VBG animals_NNS with_IN rabies_NNS virus_NN ,_, only_RB a_DT percentage_NN of_IN them_PRP will_MD be_VB able_JJ to_TO withstand_VB the_DT subdural_JJ inoculation_NN of_IN living_NN virus_NN ._.
In_IN the_DT immunising_NN experiments_NNS recorded_VBN ._.
in_IN this_DT paper_NN ,_, 8_CD animals_NNS were_VBD treated_VBN with_IN dead_JJ virus_NN ,_, and_CC afterwards_NNS trephined_VBN and_CC inoculated_VBN subdurally_RB with_IN living_NN virus_NN ,_, with_IN the_DT result_NN that_IN 6_CD remained_VBD well_RB ,_, and_CC 2_CD developed_JJ rabies_NNS ._.
The_DT 2_CD which_WDT developed_VBD rabies_NNS ,_, developed_VBD it_PRP at_IN a_DT later_JJ period_NN than_IN the_DT control_NN animals_NNS ,_, proving_VBG that_IN they_PRP were_VBD more_RBR resistant_JJ than_IN the_DT controls_NNS ._.
It_PRP is_VBZ worthy_JJ of_IN note_NN that_IN all_PDT the_DT monkeys_NNS (_( four_CD )_) treated_VBN with_IN dead_JJ vaccine_NN survived_VBD the_DT subdural_JJ inoculation_NN of_IN living_NN virulent_NN virus_NN ._.
This_DT result_NN in_IN itself_PRP is_VBZ sufficient_JJ proof_NN that_IN the_DT vaccine_NN used_VBN was_VBD efficient_JJ ,_, and_CC there_EX can_MD be_VB no_DT manner_NN of_IN doubt_NN about_IN its_PRP$ safety_NN ._.
The_DT other_JJ test_NN of_IN immunity_NN applied_VBN to_TO the_DT 8_CD animals_NNS treated_VBN with_IN a_DT dead_JJ rabies_NNS vaccine_NN was_VBD the_DT rabicidal_JJ properties_NNS of_IN the_DT serum_NN ._.
Samples_NNS of_IN blood_NN were_VBD taken_VBN (_( in_IN some_DT cases_NNS once_RB ,_, and_CC in_IN other_JJ cases_NNS twice_RB )_) before_IN the_DT animals_NNS were_VBD trephined_VBN for_IN subdural_JJ inoculation_NN ,_, and_CC when_WRB the_DT serum_NN had_VBD separated_VBN it_PRP was_VBD mixed_JJ with_IN an_DT equal_JJ volume_NN of_IN diluted_JJ living_NN rabies_NNS virus_VBP ,_, and_CC the_DT mixture_NN placed_VBN in_IN the_DT incubator_NN at_IN a_DT temperature_NN of_IN 37°C_CD for_IN 2_CD hours_NNS ._.
After_IN remaining_VBG for_IN 2_CD hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD ,_, the_DT mixture_NN was_VBD removed_VBN ,_, remixed_VBN ,_, and_CC 0.2_CD c.c_NN ._.
inoculated_VBN subdurally_RB into_IN rabbits_NNS ._.
In_IN every_DT case_NN a_DT control_NN rabbit_NN was_VBD inoculated_VBN with_IN a_DT similar_JJ preparation_NN ,_, ex-_JJ cept_NN that_IN the_DT serum_NN of_IN a_DT normal_JJ untreated_JJ animal_NN of_IN the_DT same_JJ species_NNS as_IN the_DT immu-_NN nised_VBD animal_NN was_VBD used_VBN ._.
20_CD Altogether_RB 12_CD experiments_NNS and_CC 12_CD control_NN experiments_NNS with_IN serum_NNS were_VBD carried_VBN out_RP as_IN described_VBN above_IN ,_, with_IN the_DT result_NN that_IN evidence_NN of_IN complete_JJ rabicidal_NN power_NN was_VBD present_JJ in_IN 7_CD ,_, and_CC in_IN the_DT remaining_VBG 5_CD there_EX was_VBD evidence_NN of_IN considerable_JJ rabi-_JJ cidal_NN power_NN ,_, as_IN the_DT animals_NNS developed_VBD rabies_NNS at_IN a_DT later_JJ period_NN than_IN the_DT control_NN animals_NNS in_IN which_WDT normal_JJ serum_NN was_VBD used_VBN ._.
The_DT virus_NN dilutions_NNS used_VBN in_IN these_DT rabicidal_JJ experiments_NNS were_VBD passed_VBN through_IN a_DT fine_JJ wire_NN strainer_NN to_TO keep_VB back_RP any_DT coarse_JJ particles_NNS of_IN fibrous_JJ tissue_NN which_WDT might_MD be_VB present_JJ ,_, and_CC in_IN no_DT case_NN was_VBD the_DT virus_NN passed_VBD through_IN a_DT filter_NN of_IN any_DT kind_NN ._.
1ST_CD SERIES_NN OF_NNP IMMUNISING_NNP EXPERIMENTS_NNP ._.
In_IN this_DT series_NN of_IN experiments_NNS ,_, two_CD healthy_JJ full_JJ grown_VBN monkeys_NNS each_DT weighing_VBG about_IN 15_CD lbs_NNS ._.
were_VBD immunised_VBN ._.
They_PRP were_VBD the_DT species_NNS of_IN common_JJ brown_JJ monkey_NN found_VBN in_IN the_DT hills_NNS in_IN the_DT neighbourhood_NN of_IN Kasauli_NNP ,_, and_CC had_VBD been_VBN in_IN cap-_JJ tivity_NN for_IN three_CD or_CC four_CD months_NNS before_IN being_VBG experimented_VBN on_IN ._.
Each_DT received_VBD one_CD inoculation_NN daily_RB for_IN 24_CD days_NNS of_IN a_DT 4_CD per_IN cent_NN ._.
dilution_NN of_IN dead_JJ rabies_NNS virus_VBP in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN ._.
The_DT smallest_JJS dose_JJ given_VBN was_VBD 1_CD c.c_NN ._.
and_CC the_DT largest_JJS 3_CD c.c._NN ,_, and_CC the_DT increase_NN from_IN 1_CD to_TO 3_CD c.c_NN ._.
was_VBD gradual_JJ ._.
The_DT total_JJ amount_NN of_IN vaccine_NN injected_VBN was_VBD 50_CD c.c_NN ._.
Both_DT animals_NNS remained_VBN in_IN good_JJ health_NN during_IN treatment_NN and_CC gained_VBD a_DT little_JJ in_IN weight_NN ._.
Eleven_NNP days_NNS after_IN completion_NN of_IN treatment_NN ,_, samples_NNS of_IN blood_NN were_VBD taken_VBN ,_, and_CC the_DT serum_NN tested_VBD for_IN its_PRP$ rabicidal_JJ power_NN on_IN ``_`` fixed_JJ virus_NN ._. ''_''
One_CD monkey_NN 's_POS serum_NN showed_VBD a_DT complete_JJ rabicidal_NN effect_NN on_IN an_DT equal_JJ volume_NN of_IN 1_CD in_IN 300_CD dilution_NN of_IN ``_`` fixed_JJ virus_NN ,_, ''_'' when_WRB the_DT mixture_NN of_IN serum_NN and_CC virus_NN was_VBD kept_VBN for_IN 2_CD hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD ,_, and_CC the_DT other_JJ monkey_NN 's_POS serum_NN an_DT incomplete_JJ but_CC marked_VBD rabicidal_JJ effect_NN ._.
(_( See_VB experiments_NNS 1_CD and_CC 2_CD in_IN 5th_CD series_NN ._. )_)
Fifteen_NNP days_NNS after_IN completion_NN of_IN treatment_NN both_DT monkeys_NNS were_VBD trephined_VBN and_CC inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
of_IN a_DT 1_CD in_IN 500_CD dilution_NN of_IN 2nd_CD passage_NN ``_`` street_NN virus_NN ,_, ''_'' fresh_JJ from_IN a_DT rabbit_NN 's_POS medulla_NN a_DT few_JJ hours_NNS after_IN death_NN from_IN 2nd_CD passage_NN ``_`` street_NN virus_NN ._. ''_''
Both_DT monkeys_NNS remained_VBD well_RB ._.
Two_CD control_NN rabbits_NNS were_VBD inoculated_VBN subdurally_RB with_IN the_DT same_JJ virus_NN ;_: one_CD with_IN 0.15_CD c.c_NNS ._.
of_IN 1_CD in_IN 500_CD dilution_NN ,_, and_CC the_DT other_JJ 0.15_CD c.c_NN ._.
of_IN 1_CD in_IN 1,000_CD dilution_NN ._.
The_DT former_JJ developed_NN rabies_NNS on_IN the_DT 11th_CD day_NN ,_, and_CC the_DT latter_NN on_IN the_DT 12th_CD day_NN ._.
Another_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
of_IN the_DT virus_NN used_VBN to_TO immunise_VB these_DT monkeys_NNS remained_VBD well_RB ._.
The_DT results_NNS of_IN this_DT series_NN of_IN experiments_NNS prove_VBP that_IN monkeys_NNS can_MD be_VB highly_RB immunised_VBN against_IN rabies_NNS by_IN the_DT hypodermic_JJ inoculation_NN of_IN dead_JJ ._.
rabies_NNS virus_NN ,_, when_WRB the_DT virus_NN has_VBZ been_VBN killed_VBN and_CC preserved_VBN in_IN carbolic_JJ acid_NN ._.
21_CD TABLE_NN I_PRP ._.
1ST_CD SERIES_NN OF_NNP IMMUNISING_NNP EXPERIMENTS_NNP ._.
Experiments_NNS on_IN monkeys_NNS to_TO test_VB the_DT immunising_NN properties_NNS of_IN dead_JJ rabies_NNS virus_NN ._.
The_DT virus_NN was_VBD killed_VBN by_IN exposing_VBG an_DT 8_CD per_IN cent_NN ._.
dilution_NN of_IN ``_`` fixed_JJ virus_NN ``_`` in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN to_TO a_DT temperature_NN of_IN 37°C_CD for_IN 24_CD hours_NNS ;_: it_PRP was_VBD then_RB diluted_VBN with_IN an_DT equal_JJ volume_NN of_IN normal_JJ saline_JJ solution_NN ,_, which_WDT gave_VBD 4_CD per_IN cent_NN ._.
virus_NN in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ._.
No_DT ._.
of_IN experiment_NN ._.
Duration_NN of_IN treatment_NN ._.
Total_JJ quantity_NN of_IN 4_CD per_IN cent_NN ,_, dead_JJ rabies_NNS virus_VBP injected_VBN sub-_JJ cutaneously_RB ._.
Test_NN to_TO which_WDT subjected_VBN ._.
Result_NN ._.
REMARKS_NNP ._.
1_CD ._.
Monkey_NNP One_CD injection_NN daily_RB for_IN 24_CD days_NNS ._.
50_CD c.c_NN ._.
15_CD days_NNS after_IN completion_NN of_IN treatment_NN ,_, was_VBD tre-_JJ phined_JJ and_CC inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
of_IN 1_CD in_IN 500_CD dilution_NN of_IN 2nd_CD passage_NN ``_`` street_NN virus_JJ ``_`` fresh_JJ from_IN a_DT rabbit_NN 's_POS medulla_NN ._.
Remained_VBN well_RB ._.
2_CD ._.
Monkey_NNP Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
3_CD ._.
Rabbit_NN ._.
Con-_NNP trol_NN of_IN test_NN virus_NN ._.
.._JJ .._NN Trephined_VBN and_CC inocu-_JJ lated_VBN subdurally_RB with_IN 0.15_CD c.c_NNS ._.
of_IN 1_CD in_IN 500_CD dilution_NN of_IN the_DT same_JJ virus_NN used_VBN to_TO test_VB the_DT two_CD monkeys_NNS ._.
Rabies_NNS ,_, 11th_CD day_NN ._.
4_CD ._.
Rabbit_NNP ,_, 2nd_CD control_NN of_IN test_NN virus_NN ._.
.._NNS .._VBP
Same_NNP as_IN No_NNP ._.
3_CD experi-_JJ ment_NN ,_, with_IN the_DT excep-_JJ tion_NN that_IN 1_CD in_IN 1,000_CD dilution_NN of_IN test_NN virus_NN was_VBD used_VBN ._.
Rabies_NNS ,_, 12th_CD day_NN ._.
5_CD ._.
Rabbit_NN ._.
Con-_NNP trol_NN of_IN immu-_JJ nising_JJ virus_NN ._.
.._JJ .._NN Trephined_VBN and_CC inocu-_JJ lated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
of_IN the_DT virus_NN used_VBN for_IN immunising_VBG Nos_NNP ._.
1_CD and_CC 2_CD monkeys_NNS ._.
Remained_VBN well_RB ._.
2ND_CD SERIES_NN OF_NNP IMMUNISING_NNP EXPERIMENTS_NNP ._.
In_IN this_DT series_NN two_CD healthy_JJ full_JJ grown_JJ monkeys_NNS of_IN a_DT similar_JJ species_NNS to_TO the_DT two_CD used_VBD for_IN the_DT 1st_CD series_NN of_IN experiments_NNS were_VBD immunised_VBN ._.
Each_DT weighed_VBD about_IN 16_CD lbs_NNS ._.
;_: and_CC they_PRP had_VBD been_VBN in_IN captivity_NN for_IN three_CD months_NNS before_IN being_VBG experimented_VBN on_IN ._.
Both_DT received_VBD the_DT same_JJ treatment_NN ,_, viz._NN ,_, one_CD hypodermic_JJ injection_NN daily_RB for_IN 24_CD days_NNS of_IN a_DT 4_CD per_IN cent_NN ._.
dilution_NN of_IN dead_JJ rabies_NNS virus_VBP in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN ._.
The_DT smallest_JJS dose_JJ given_VBN was_VBD 1_CD c.c_NN ._.
and_CC the_DT largest_JJS 3½_CD c.c._NN ,_, and_CC the_DT increase_NN from_IN 1_CD c.c_NN ._.
at_IN the_DT outset_NN to_TO 3½_CD c.c_NN ._.
later_RB on_IN was_VBD gradual_JJ ._.
No_DT change_NN was_VBD apparent_JJ in_IN the_DT condition_NN of_IN their_PRP$ health_NN during_IN treatment_NN ._.
Fourteen_NNP days_NNS after_IN the_DT completion_NN of_IN treatment_NN samples_NNS of_IN blood_NN were_VBD taken_VBN to_TO test_VB for_IN rabicidal_NN properties_NNS of_IN the_DT serum_NN ._.
The_DT test_NN applied_VBD to_TO the_DT serum_NN of_IN these_DT two_CD monkeys_NNS was_VBD carried_VBN out_RP in_IN a_DT manner_NN similar_JJ to_TO the_DT test_NN applied_VBD to_TO the_DT serum_NN of_IN the_DT two_CD monkeys_NNS referred_VBD to_TO in_IN the_DT 1st_JJ series_NN of_IN experiments_NNS ,_, except_IN that_IN a_DT 1_CD in_IN 200_CD dilution_NN of_IN 1st_CD passage_NN human_JJ virus_NN ,_, fresh_JJ from_IN the_DT medulla_NN of_IN a_DT rabbit_NN which_WDT had_VBD died_VBN from_IN subdural_JJ inoculation_NN of_IN a_DT portion_NN of_IN the_DT brain_NN of_IN a_DT hydro-_JJ [_NN NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75058177.tif_CD ]_JJ 22_CD phobia_JJ patient_NN ,_, was_VBD used_VBN ._.
One_CD monkey_NN 's_POS serum_NN showed_VBD a_DT complete_JJ rabicidal_NN effect_NN on_IN an_DT equal_JJ volume_NN of_IN 1_CD in_IN 200_CD 1st_CD passage_NN human_JJ virus_NN ;_: and_CC the_DT other_JJ monkey_NN 's_POS serum_NN an_DT incomplete_JJ but_CC marked_JJ effect_NN ._.
On_IN the_DT fifteenth_JJ day_NN after_IN completion_NN of_IN treatment_NN both_DT monkeys_NNS were_VBD tre-_JJ phined_JJ and_CC inoculated_VBN subdurally_RB with_IN 0.3_CD c.c_NNS ._.
of_IN a_DT 1_CD in_IN 600_CD dilution_NN of_IN 1st_CD passage_NN human_JJ virus_NN freshly_RB prepared_VBN from_IN the_DT medulla_NN of_IN a_DT rabbit_NN which_WDT had_VBD died_VBN from_IN rabies_NNS after_IN the_DT subdural_JJ inoculation_NN of_IN a_DT portion_NN of_IN brain_NN from_IN a_DT hydrophobia_JJ patient_NN ._.
Both_DT monkeys_NNS remained_VBD well_RB ._.
A_DT control_NN monkey_NN inoculated_VBN subdurally_RB with_IN 0.3_CD c.c_NNS ._.
of_IN a_DT 1_CD in_IN 600_CD dilution_NN of_IN the_DT same_JJ virus_NN used_VBN to_TO test_VB the_DT two_CD immunised_JJ monkeys_NNS developed_VBD furious_JJ rabies_NNS on_IN the_DT 10th_JJ day_NN ,_, and_CC died_VBD on_IN the_DT 13th_JJ day_NN ._.
A_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
of_IN a_DT 1_CD in_IN 600_CD dilution_NN of_IN the_DT same_JJ virus_NN also_RB developed_VBD rabies_NNS on_IN the_DT 10th_JJ day_NN ,_, the_DT same_JJ period_NN as_IN the_DT con-_JJ trol_NN monkey_NN ._.
Another_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
of_IN the_DT virus_NN used_VBN to_TO immunise_VB the_DT two_CD monkeys_NNS remained_VBD well_RB ._.
The_DT results_NNS of_IN this_DT series_NN of_IN experiments_NNS are_VBP additional_JJ proof_NN that_IN monkeys_NNS can_MD be_VB highly_RB immunised_VBN by_IN the_DT hypodermic_JJ inoculation_NN of_IN dead_JJ rabies_NNS virus_NN ,_, when_WRB the_DT virus_NN has_VBZ been_VBN killed_VBN and_CC preserved_VBN in_IN carbolic_JJ acid_NN ._.
TABLE_NNP II_NNP ._.
2ND_CD SERIES_NN OF_NNP IMMUNISING_NNP EXPERIMENTS_NNP ._.
Experiments_NNS on_IN monkeys_NNS to_TO test_VB the_DT immunising_NN properties_NNS of_IN dead_JJ rabies_NNS virus_NN ._.
The_DT virus_NN was_VBD killed_VBN by_IN exposing_VBG an_DT 8_CD per_IN cent_NN ._.
dilution_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN to_TO a_DT temperature_NN of_IN 37ºC_CD ._.
for_IN 24_CD hours_NNS ;_: it_PRP was_VBD then_RB diluted_VBN with_IN an_DT equal_JJ volume_NN of_IN normal_JJ saline_JJ solution_NN ,_, which_WDT gave_VBD 4_CD per_IN cent_NN ._.
virus_NN in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ._.
No_DT ._.
of_IN experiment_NN ._.
Duration_NN of_IN treatment_NN ._.
Total_JJ quantity_NN of_IN 4_CD per_IN cent_NN ._.
dead_JJ rabies_NNS virus_VBP injected_VBN sub-_JJ cutaneously_RB ._.
Test_NN to_TO which_WDT subjected_VBN ._.
Result_NN ._.
REMARKS_NNP ._.
1_CD ._.
Monkey_NNP One_CD injection_NN daily_RB for_IN 24_CD days_NNS ._.
60_CD c.c_NN ._.
15_CD days_NNS after_IN completion_NN of_IN treatment_NN was_VBD tre-_JJ phined_JJ and_CC inoculated_VBN subdurally_RB with_IN 0.3_CD c.c_NNS ._.
of_IN 1_CD in_IN 600_CD dilution_NN of_IN 1st_CD passage_NN human_JJ virus_NN ,_, fresh_JJ from_IN a_DT rabbit_NN 's_POS medulla_NN ._.
Remained_VBN well_RB ._.
2_CD ._.
Monkey_NNP Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
3_CD ._.
Monkey_NNP ._.
Con-_NNP trol_NN of_IN test_NN virus_NN ._.
.._JJ .._NN Trephined_VBN and_CC inocu-_JJ lated_VBN with_IN 0.3_CD c.c_NNS ._.
of_IN same_JJ virus_NN used_VBN for_IN ex-_JJ periments_NNS 1_CD and_CC 2_CD ._.
Rabies_NNS ,_, 10th_CD day_NN ._.
4_CD ._.
Rabbit_NN ._.
2nd_CD control_NN of_IN test_NN virus_NN ._.
.._NNS .._VBP
Same_NNP as_IN above_IN ,_, but_CC only_RB 0.2_CD c.c_NN ._.
used_VBN ._.
Ditto_NNP ._.
5_CD ._.
Rabbit_NN ._.
Con-_NNP trol_NN of_IN immu-_JJ nising_JJ virus_NN ._.
.._JJ .._NN Trephined_VBN and_CC inocu-_JJ lated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
of_IN the_DT virus_NN used_VBN for_IN immunising_VBG Nos_NNP ._.
1_CD and_CC 2_CD monkeys_NNS ._.
Remained_VBN well_RB ._.
23_CD 3RD_CD SERIES_NN OF_NNP IMMUNISING_NNP EXPERIMENTS_NNP ._.
The_DT experiments_NNS in_IN this_DT series_NN were_VBD carried_VBN out_RP on_IN two_CD dogs_NNS ._.
One_CD was_VBD a_DT full_JJ grown_NN animal_NN and_CC weighed_VBD 24_CD lbs_NN ._.
;_: the_DT other_JJ was_VBD a_DT little_RB more_JJR than_IN half_JJ grown_JJ (_( a_DT puppy_NN )_) and_CC weighed_VBD 10_CD lbs_NN ._.
at_IN the_DT commencement_NN of_IN treatment_NN ,_, and_CC 13_CD lbs_NN ._.
on_IN completion_NN ._.
Both_DT were_VBD treated_VBN with_IN hypodermic_JJ injections_NNS of_IN 4_CD per_IN cent_NN ._.
dead_JJ rabies_NNS virus_VBP in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN ,_, and_CC were_VBD given_VBN one_CD dose_JJ daily_JJ for_IN 28_CD days_NNS ._.
The_DT doses_NNS varied_VBD from_IN 1½_CD c.c_NN ._.
to_TO 4_CD c.c_NN ._.
in_IN the_DT larger_JJR dog_NN ,_, and_CC from_IN 1_CD c.c_NN ._.
to_TO 3_CD c.c_NN ._.
in_IN the_DT smaller_JJR animal_NN ._.
The_DT total_JJ amount_NN of_IN vaccine_NN given_VBN to_TO the_DT larger_JJR dog_NN was_VBD 100_CD c.c._NN ,_, and_CC to_TO the_DT smaller_JJR one_CD 90_CD c.c_NN ._.
On_IN the_DT 11th_CD day_NN after_IN completion_NN of_IN treatment_NN samples_NNS of_IN blood_NN were_VBD taken_VBN from_IN both_DT clogs_NNS to_TO test_VB the_DT rabicidal_NN properties_NNS of_IN the_DT serum_NN on_IN ``_`` fixed_JJ virus_NN ._. ''_''
The_DT serum_NN in_IN both_DT cases_NNS gave_VBD a_DT complete_JJ rabicidal_NN effect_NN when_WRB mixed_JJ with_IN equal_JJ parts_NNS of_IN a_DT 1_CD in_IN 300_CD dilution_NN of_IN ``_`` fixed_JJ virus_NN ,_, ''_'' and_CC kept_VBD for_IN 2_CD hours_NNS at_IN a_DT tem-_JJ perature_NN of_IN 37°C_CD ._.
On_IN the_DT 23rd_CD day_NN after_IN completion_NN of_IN treatment_NN the_DT serum_NN of_IN both_DT dogs_NNS was_VBD again_RB tested_VBN for_IN its_PRP$ rabicidal_JJ effect_NN ,_, and_CC this_DT time_NN on_IN a_DT 1_CD in_IN 300_CD dilution_NN of_IN ``_`` street_NN virus_NN ''_'' (_( 2nd_CD passage_NN jackal_NN 's_POS virus_NN )_) with_IN the_DT result_NN that_WDT although_IN the_DT effect_NN was_VBD incomplete_JJ it_PRP was_VBD marked_VBN in_IN both_DT cases_NNS ._.
(_( See_VB experiments_NNS 5_CD and_CC 6_CD in_IN 5th_CD series_NN ._. )_)
In_IN both_DT these_DT dogs_NNS either_CC the_DT rabicidal_JJ power_NN of_IN the_DT serum_NN was_VBD higher_JJR on_IN the_DT 11th_CD day_NN than_IN on_IN the_DT 23rd_CD day_NN after_IN completion_NN of_IN treatment_NN ,_, or_CC possibly_RB ``_`` fixed_JJ virus_NN ``_`` was_VBD more_RBR easily_RB killed_VBN than_IN 2nd_CD passage_NN jackal_NN 's_POS virus_NN ._.
Twenty-four_CD days_NNS after_IN completion_NN of_IN treatment_NN both_DT dogs_NNS were_VBD trephined_VBN and_CC inoculated_VBN subdurally_RB with_IN 0.3_CD c.c_NNS ._.
of_IN a_DT 1_CD in_IN 600_CD 2nd_CD passage_NN jackal_NN 's_POS virus_NN fresh_NN from_IN a_DT rabbit_NN 's_POS medulla_NN ._.
The_DT large_JJ dog_NN remained_VBD well_RB ,_, and_CC the_DT puppy_JJ dog_NN developed_VBD rabies_NNS on_IN the_DT 29th_CD day_NN ._.
A_DT control_NN dog_NN inoculated_VBD subdurally_RB with_IN 0.3_CD c.c_NNS ._.
of_IN 1_CD in_IN 600_CD of_IN the_DT same_JJ virus_NN used_VBN to_TO test_VB the_DT two_CD immunised_JJ dogs_NNS deve-_JJ loped_JJ rabies_NNS on_IN the_DT 10th_JJ day_NN ._.
A_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
of_IN the_DT virus_NN used_VBN to_TO immunise_VB the_DT two_CD dogs_NNS remained_VBD well_RB ._.
The_DT results_NNS of_IN this_DT series_NN of_IN experiments_NNS show_VBP that_IN of_IN two_CD dogs_NNS treated_VBN with_IN dead_JJ rabies_NNS virus_NN ,_, one_CD was_VBD so_RB highly_RB immunised_JJ as_IN to_TO be_VB able_JJ to_TO withstand_VB the_DT subdural_JJ inoculation_NN of_IN a_DT certain_JJ lethal_JJ dose_NN of_IN living_NN rabies_NNS virus_VBP ,_, and_CC the_DT other_JJ almost_RB succeeded_VBN in_IN reaching_VBG this_DT degree_NN of_IN immunity_NN ,_, as_IN evidenced_VBN by_IN the_DT fact_NN that_IN the_DT incubation_NN period_NN after_IN subdural_JJ inoculation_NN was_VBD 29_CD days_NNS as_IN compared_VBN with_IN 10_CD days_NNS in_IN the_DT control_NN dog_NN ._.
E_RB 24_CD TABLE_NNP III_NNP ._.
3RD_CD SERIES_NN OF_NNP IMMUNISING_NNP EXPERIMENTS_NNP ._.
Experiments_NNS on_IN dogs_NNS to_TO test_VB the_DT immunising_NN properties_NNS of_IN dead_JJ rabies_NNS virus_NN ._.
The_DT virus_NN was_VBD killed_VBN by_IN exposing_VBG an_DT 8_CD per_IN cent_NN ._.
dilution_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN to_TO a_DT temperature_NN of_IN 37ºC_CD ._.
for_IN 24_CD hours_NNS ;_: it_PRP was_VBD then_RB diluted_VBN with_IN an_DT equal_JJ volume_NN of_IN normal_JJ saline_JJ solution_NN ,_, which_WDT gave_VBD 4_CD per_IN cent_NN ._.
virus_NN in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ._.
No_DT ._.
of_IN experiment_NN ._.
Duration_NN of_IN treatment_NN ._.
Total_JJ quantity_NN of_IN 4_CD per_IN cent_NN ._.
dead_JJ rabies_NNS virus_VBP injected_VBN sub-_JJ cutaneously_RB ._.
Test_NN to_TO which_WDT subjected_VBN ._.
Result_NN ._.
REMARKS_NNP ._.
1_CD ._.
Dog_NNP ,_, weight_VBD 24_CD lbs._NN ,_, full_JJ grown_NN ._.
One_CD injection_NN daily_RB for_IN 28_CD days_NNS ._.
100_CD c.c_NN ._.
24_CD days_NNS after_IN completion_NN of_IN treatment_NN ,_, was_VBD tre-_JJ phined_JJ and_CC inoculated_VBN subdurally_RB with_IN 0.3_CD c.c_NNS ._.
of_IN 1_CD in_IN 600_CD dilution_NN 2nd_CD passage_NN jackal_NN 's_POS virus_NN ,_, fresh_JJ from_IN a_DT rabbit_NN 's_POS medulla_NN ._.
Remained_VBN well_RB ._.
2_CD ._.
Puppy_JJ dog_NN ,_, weight_VBD 13_CD lbs_NN ._.
Ditto_NNP ._.
90_CD c.c_NN ._.
Ditto_NNP ._.
Rabies_NNS ,_, 29th_CD day_NN ._.
3_CD ._.
Control_NNP dog_NN weight_VBD 14_CD lbs_NN ._.
full_JJ grown_NN ._.
.._JJ .._NN Trephined_VBN and_CC inocu-_JJ lated_VBN subdurally_RB with_IN 0.3_CD c.c_NNS ._.
of_IN 1_CD in_IN 600_CD dilution_NN of_IN same_JJ virus_NN used_VBN to_TO test_VB Nos_NNP ._.
1_CD and_CC 2_CD dogs_NNS ._.
Rabies_NNS ,_, 10th_CD day_NN ._.
4_CD ._.
Rabbit_NN ._.
Con-_NNP trol_NN of_IN immu-_JJ nising_JJ virus_NN ._.
.._JJ .._NN Trephined_VBN and_CC inocu-_JJ lated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
of_IN the_DT virus_NN used_VBN for_IN immunising_VBG Nos_NNP ._.
1_CD and_CC 2_CD dogs_NNS ._.
Remained_VBN well_RB ._.
4TH_CD SERIES_NN OF_NNP IMMUNISING_NNP EXPERIMENTS_NNP ._.
The_DT experiments_NNS in_IN this_DT series_NN were_VBD carried_VBN out_RP on_IN rabbits_NNS ._.
Two_CD healthy_JJ full_JJ grown_VBN rabbits_NNS each_DT weighing_VBG 2½_CD kilogrammes_NNS were_VBD immunised_VBN with_IN 2_CD per_IN cent_NN ._.
dilutions_NNS of_IN dead_JJ rabies_NNS virus_VBP in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN ._.
They_PRP received_VBD one_CD hypodermic_JJ injection_NN daily_RB for_IN 24_CD days_NNS ._.
The_DT doses_NNS varied_VBD from_IN 0.5_CD c.c_NN ._.
at_IN the_DT outset_NN ,_, to_TO 2_CD c.c_NN ._.
later_RB on_IN ,_, and_CC the_DT increase_NN from_IN the_DT smaller_JJR to_TO the_DT larger_JJR doses_NNS was_VBD gradual_JJ ._.
The_DT total_JJ amount_NN of_IN vaccine_NN given_VBN to_TO each_DT animal_NN was_VBD 36_CD c.c_NN ._.
On_IN the_DT 8th_CD day_NN after_IN completion_NN of_IN treatment_NN the_DT serum_NN of_IN both_DT animals_NNS gave_VBD a_DT complete_JJ rabicidal_NN effect_NN when_WRB mixed_NN with_IN a_DT 1_CD in_IN 200_CD dilution_NN of_IN ``_`` fixed_JJ virus_NN ''_'' and_CC kept_VBD for_IN 2_CD hours_NNS at_IN a_DT temperature_NN of_IN 37ºC_CD ._.
On_IN the_DT 25th_JJ day_NN the_DT serum_NN was_VBD again_RB tested_VBN on_IN a_DT 1_CD in_IN 200_CD dilution_NN of_IN ``_`` fixed_JJ virus_NN ''_'' when_WRB the_DT rabicidal_NN effect_NN was_VBD found_VBN to_TO be_VB complete_JJ in_IN one_CD ,_, and_CC incomplete_JJ ,_, but_CC marked_VBD in_IN the_DT other_JJ ._.
On_IN the_DT 25th_JJ day_NN after_IN completion_NN of_IN treatment_NN both_DT rabbits_NNS were_VBD trephined_VBN and_CC inoculated_VBN subdurally_RB with_IN 0.25_CD c.c_NNS ._.
of_IN a_DT 1_CD in_IN 200_CD dilution_NN of_IN 2nd_CD passage_NN ``_`` street_NN 25_CD virus_NN ''_'' fresh_NN from_IN the_DT medulla_NN of_IN a_DT rabbit_NN dead_JJ from_IN 2nd_CD passage_NN ``_`` street_NN virus_NN ''_'' rabies_NNS ._.
One_CD rabbit_NN remained_VBD well_RB and_CC the_DT other_JJ (_( the_DT one_CD whose_WP$ serum_NN gave_VBD a_DT incomplete_JJ rabicidal_NN effect_NN on_IN the_DT 25th_JJ day_NN )_) developed_VBD rabies_NNS on_IN the_DT 16th_CD day_NN ._.
A_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN a_DT 1_CD in_IN 400_CD dilution_NN (_( i.e._FW ,_, half_PDT the_DT strength_NN )_) of_IN the_DT same_JJ virus_NN used_VBN to_TO test_VB the_DT two_CD immunised_JJ animals_NNS developed_VBD rabies_NNS on_IN the_DT 10th_JJ day_NN ._.
Another_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN 0.25_CD c.c_NNS ._.
of_IN this_DT virus_NN used_VBN to_TO immunise_VB the_DT two_CD rabbits_NNS remained_VBN well_RB ._.
The_DT results_NNS of_IN this_DT series_NN of_IN experiments_NNS show_VBP that_IN rabbits_NNS can_MD be_VB immunised_VBN with_IN hypodermic_JJ injections_NNS of_IN dead_JJ rabies_NNS virus_VBP ;_: and_CC of_IN two_CD rabbits_NNS immunised_VBN by_IN this_DT method_NN one_CD attained_VBD a_DT degree_NN of_IN immunity_NN sufficient_NN to_TO withstand_VB the_DT subdural_JJ inoculation_NN of_IN virulent_JJ rabies_NNS virus_NN ,_, and_CC the_DT other_JJ almost_RB succeeded_VBN in_IN attaining_VBG this_DT degree_NN of_IN immunity_NN ._.
The_DT test_NN applied_VBD to_TO these_DT two_CD rabbits_NNS was_VBD a_DT very_RB severe_JJ one_CD ,_, viz._NN ,_, the_DT subdural_JJ inoculation_NN of_IN 0.25_CD c.c_NN ._.
of_IN a_DT 1_CD in_IN 200_CD dilution_NN of_IN virus_NN ._.
A_DT more_RBR highly_RB diluted_VBN virus_NN such_JJ as_IN 1_CD in_IN 600_CD or_CC 1_CD in_IN 1,000_CD would_MD have_VB been_VBN a_DT fairer_JJ test_NN ._.
TABLE_NNP IV_NNP ._.
4TH_CD SERIES_NN OF_NNP IMMUNISING_NNP EXPERIMENTS_NNP ._.
Experiments_NNS on_IN rabbits_NNS to_TO test_VB the_DT immunising_NN properties_NNS of_IN dead_JJ rabies_NNS virus_NN ._.
The_DT virus_NN used_VBN was_VBD killed_VBN by_IN exposing_VBG a_DT 4_CD per_IN cent_NN ._.
dilution_NN of_IN ``_`` fixed_JJ virus_NN ''_'' in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN to_TO a_DT temperature_NN of_IN 37°C_CD ._.
for_IN 21_CD hours_NNS ;_: it_PRP was_VBD then_RB diluted_VBN with_IN an_DT equal_JJ volume_NN of_IN normal_JJ saline_JJ solution_NN ,_, which_WDT gave_VBD 2_CD per_IN cent_NN ._.
virus_NN in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ._.
No_DT ._.
of_IN experi-_JJ ment_NN ._.
Duration_NN of_IN treatment_NN ._.
Total_JJ quantity_NN of_IN 2_CD per_IN cent_NN ._.
dead_JJ rabies_NNS virus_VBP injected_VBN sub-_JJ cutaneously_RB ._.
Test_NN to_TO which_WDT subjected_VBN ._.
Results_NNS ._.
REMARKS_NNP ._.
1_CD One_CD injection_NN daily_RB for_IN 24_CD days_NNS ._.
36_CD c.c_NN ._.
25_CD days_NNS after_IN completion_NN of_IN treatment_NN was_VBD tre-_JJ phined_JJ and_CC inoculated_VBN subdurally_RB with_IN 0.25_CD c.c_NNS ._.
of_IN 1_CD in_IN 200_CD dilution_NN of_IN 2nd_CD passage_NN ``_`` street_NN virus_NN ''_'' fresh_NN from_IN a_DT rabbit_NN 's_POS medulla_NN ._.
Remained_VBN well_RB ._.
The_DT test_NN ap-_NN plied_VBD to_TO these_DT two_CD experiments_NNS (_( Nos_NNP ._.
1_CD and_CC 2_CD )_) was_VBD a_DT severe_JJ one_CD ,_, as_IN the_DT virus_NN used_VBN was_VBD diluted_VBN only_RB to_TO 1_CD in_IN 200_CD ._.
2_CD Ditto_NNP Ditto_NNP Ditto_NNP ditto_NN Rabies_NNP ,_, 16th_CD day_NN ._.
3_CD ._.
Control_NN of_IN test_NN virus_NN ._.
.._JJ .._NN Trephined_NNP and_CC inoculated_VBN subdurally_RB with_IN 0.25_CD c.c_NNS ._.
of_IN 1_CD in_IN 400_CD dilution_NN of_IN same_JJ virus_NN used_VBN for_IN experiments_NNS 1_CD and_CC 2_CD ._.
Rabies_NNS ,_, 10th_CD day_NN ._.
4_CD ._.
Control_NN of_IN immunising_VBG virus_NN ._.
.._JJ .._NN Trephined_NNP and_CC inoculated_VBN subdurally_RB with_IN 0.25_CD c.c_NNS ._.
of_IN virus_NN used_VBN for_IN the_DT immunising_VBG experi-_JJ ments_NNS 1_CD and_CC 2_CD ._.
Remained_VBN well_RB ._.
E_RB 2_CD 26_CD CHAPTER_NN VI_NNP ._.
The_DT Evidence_NN of_IN Immunity_NNP in_IN the_DT Serum_NNP of_IN Animals_NNP treated_VBD with_IN Rabies_NNP Virus_NNP killed_VBN by_IN Carbolic_NNP Acid_NNP ._.
SERIES_NNP V._NNP EXPERIMENTS_NNP TO_NNP TEST_NNP THE_NNP RABICIDAL_NNP PROPERTIES_NNP OF_IN THE_NNP SERUM_NNP OF_NNP ANIMALS_NNP IMMUNISED_NNP WITH_NNP DEAD_NNP RABIES_NNP VIRUS_NNP ._.
This_DT series_NN of_IN experiments_NNS gives_VBZ the_DT rabicidal_NN properties_NNS of_IN the_DT serum_NN of_IN the_DT eight_CD animals_NNS (_( four_CD monkeys_NNS ,_, two_CD dogs_NNS ,_, and_CC two_CD rabbits_NNS )_) immunised_VBD with_IN 4_CD per_IN cent_NN ._.
dead_JJ virus_NN in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN referred_VBD to_TO in_IN series_NN I_PRP ,_, II_NNP ,_, III_NNP ,_, and_CC IV_NNP ._.
In_IN each_DT of_IN these_DT experiments_NNS blood_NN was_VBD taken_VBN in_IN glass_NN capsules_NNS and_CC put_VB aside_RB at_IN room_NN temperature_NN for_IN 24_CD hours_NNS until_IN the_DT serum_NN had_VBD separated_VBN ._.
The_DT serum_NN was_VBD then_RB pipetted_VBN off_RP and_CC mixed_JJ with_IN an_DT equal_JJ volume_NN of_IN 1_CD in_IN 200_CD or_CC 1_CD in_IN 300_CD dilution_NN of_IN living_NN rabies_NNS virus_VBP in_IN normal_JJ saline_JJ solution_NN as_IN recorded_JJ opposite_JJ each_DT experi-_JJ ment_NN ._.
The_DT mixture_NN was_VBD then_RB placed_VBN in_IN an_DT incubator_NN at_IN a_DT temperature_NN of_IN 37°C_CD for_IN two_CD hours_NNS ,_, after_IN which_WDT it_PRP was_VBD re-mixed_JJ and_CC 0.2_CD c.c_NN ._.
inoculated_VBN subdurally_RB into_IN rabbits_NNS ._.
In_IN each_DT case_NN a_DT control_NN rabbit_NN was_VBD inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
of_IN an_DT exactly_RB similar_JJ mixture_NN as_IN regards_NNS the_DT dilution_NN of_IN virus_NN and_CC kind_NN of_IN virus_NN used_VBN ,_, except_IN that_IN the_DT serum_NN added_VBD was_VBD from_IN a_DT normal_JJ monkey_NN ,_, dog_NN ,_, or_CC rabbit_NN ,_, as_IN the_DT case_NN might_MD be_VB and_CC kept_VB for_IN the_DT same_JJ time_NN (_( 2_CD hours_NNS )_) at_IN 37°C_CD ._.
On_IN referring_VBG to_TO the_DT table_NN (_( Series_NNP V_NNP )_) it_PRP will_MD be_VB seen_VBN that_IN 12_CD experiments_NNS were_VBD carried_VBN out_RP with_IN the_DT serum_NN from_IN 8_CD immunised_JJ animals_NNS ,_, and_CC that_IN in_IN 7_CD of_IN these_DT experi-_JJ ments_NNS the_DT serum_NN showed_VBD a_DT complete_JJ rabicidal_NN action_NN ,_, and_CC in_IN 5_CD an_DT incomplete_JJ but_CC marked_JJ action_NN ._.
It_PRP was_VBD a_DT mistake_NN perhaps_RB ,_, not_RB to_TO have_VB filtered_VBN the_DT rabies_NNS emulsions_NNS before_IN adding_VBG them_PRP to_TO the_DT serum_NN to_TO be_VB tested_VBN ._.
They_PRP were_VBD only_RB passed_VBN through_IN a_DT fine_JJ wire_NN strainer_NN to_TO keep_VB back_RB coarse_JJ particles_NNS of_IN fibrous_JJ tissue_NN ._.
However_RB ,_, the_DT results_NNS as_IN they_PRP stand_VBP show_VB a_DT complete_JJ rabicidal_NN action_NN in_IN 7_CD ,_, and_CC a_DT well_RB marked_JJ action_NN in_IN 5_CD ._.
In_IN the_DT 12_CD control_NN experiments_VBZ the_DT animals_NNS developed_VBD rabies_NNS after_IN an_DT incuba-_JJ tion_NN period_NN which_WDT corresponded_VBD to_TO the_DT normal_JJ incubation_NN period_NN of_IN the_DT virus_NN used_VBN ._.
The_DT results_NNS of_IN these_DT experiments_NNS prove_VBP that_IN the_DT serum_NN of_IN animals_NNS immunised_VBN with_IN rabies_NNS virus_VBP killed_VBN and_CC preserved_VBN in_IN carbolic_JJ acid_NN has_VBZ a_DT well_RB marked_VBN rabicidal_JJ effect_NN on_IN living_NN rabies_NNS virus_VBP ._.
27_CD When_WRB we_PRP examine_VBP the_DT results_NNS recorded_VBD in_IN Tables_NNP VII_NNP ,_, VIII_NNP and_CC IX_NNP ,_, in_IN which_WDT the_DT effects_NNS of_IN normal_JJ saline_JJ solution_NN on_IN various_JJ dilutions_NNS of_IN rabies_NNS virus_VBP at_IN a_DT tem-_JJ perature_NN of_IN 37°C_CD and_CC at_IN room_NN temperature_NN are_VBP given_VBN ,_, it_PRP is_VBZ evident_JJ that_IN the_DT normal_JJ saline_JJ solution_NN used_VBN to_TO dilute_VB the_DT virus_NN was_VBD not_RB the_DT cause_NN of_IN the_DT rabicidal_JJ action_NN at-_RB tributed_VBD to_TO the_DT serum_NN in_IN Series_NNP V._NNP In_IN 1891_CD Babes_NNP demonstrated_VBD the_DT fact_NN that_IN the_DT serum_NN of_IN animals_NNS immunised_VBN against_IN rabies_NNS had_VBD a_DT well_RB marked_VBN rabicidal_JJ action_NN on_IN living_NN rabies_NNS virus_VBP in_IN vitro_NN ._.
Marie1_NNP mentions_NNS that_WDT Kraus_NNP and_CC Kreissl_NNP have_VBP studied_VBN the_DT rabicidal_NN properties_NNS of_IN the_DT serum_NN of_IN patients_NNS during_IN and_CC after_IN completion_NN of_IN Pasteur_NNP 's_POS method_NN of_IN antirabic_JJ treatment_NN and_CC found_VBD evidence_NN of_IN rabicidal_NN properties_NNS 22_CD days_NNS after_IN the_DT completion_NN of_IN treatment_NN ,_, but_CC not_RB during_IN or_CC immediately_RB after_IN treat-_JJ ment_NN ._.
Lamb_NNP and_CC McKendrick,2_NNP in_IN 1908_CD ,_, tested_VBD the_DT serum_NN of_IN patients_NNS whom_WP they_PRP had_VBD treated_VBN by_IN Högyes_NNP '_POS dilution_NN method_NN of_IN treatment_NN ,_, and_CC failed_VBD to_TO obtain_VB any_DT evi-_JJ dence_NN of_IN rabicidal_NN properties_NNS in_IN the_DT serum_NN ._.
In_IN 1903-04-05_CD ,_, when_WRB Director_NNP of_IN the_DT Pasteur_NNP Institute_NNP of_IN India_NNP ,_, I_PRP carried_VBD out_RP a_DT series_NN of_IN experiments_NNS on_IN the_DT serum_NN of_IN patients_NNS after_IN undergoing_VBG Pasteur_NNP 's_POS method_NN of_IN treatment_NN ,_, and_CC obtained_VBD evidence_NN of_IN well_RB marked_VBN rabicidal_JJ effects_NNS a_DT few_JJ days_NNS after_IN completion_NN of_IN treatment_NN ._.
In_IN another_DT series_NN of_IN experiments_NNS carried_VBD out_RP at_IN the_DT same_JJ time_NN in_IN which_WDT two_CD ponies_NNS were_VBD highly_RB immunised_VBN by_IN com-_JJ mencing_NN with_IN dead_JJ virus_NN ,_, and_CC going_VBG on_IN to_TO living_VBG ``_`` fixed_VBN virus_NN ,_, ''_'' the_DT serum_NN was_VBD so_RB highly_RB rabicidal_JJ that_IN one_CD volume_NN added_VBD to_TO two_CD volumes_NNS of_IN a_DT 5_CD per_IN cent_NN ._.
dilution_NN of_IN fixed_JJ virus_NN completely_RB destroyed_VBD its_PRP$ virulence_NN in_IN ten_JJ minutes_NNS at_IN room_NN temperature.3_NN Babes_NNP ,_, Remlinger_NNP ,_, Marie_NNP and_CC other_JJ workers_NNS have_VBP obtained_VBN similar_JJ evidence_NN of_IN the_DT rabicidal_NN properties_NNS of_IN the_DT serum_NN of_IN animals_NNS immunised_VBN with_IN rabies_NNS virus_NNS ._.
The_DT serum_NN of_IN normal_JJ untreated_JJ man_NN or_CC animals_NNS does_VBZ not_RB furnish_VB any_DT evidence_NN of_IN rabicidal_JJ action_NN ._.
It_PRP is_VBZ evident_JJ from_IN these_DT experiments_NNS that_IN the_DT rabicidal_JJ action_NN of_IN the_DT serum_NN of_IN animals_NNS treated_VBN with_IN a_DT rabies_NNS vaccine_NN is_VBZ one_CD of_IN the_DT factors_NNS which_WDT indicate_VBP immunity_NN ._.
1_CD Marie28_NNP TABLE_NNP V._NNP RABICIDAL_NNP PROPERTIES_NNP OF_NNP SERUM_NNP ._.
Experiments_NNS on_IN rabbits_NNS to_TO test_VB the_DT rabicidal_NN properties_NNS of_IN the_DT serum_NN of_IN animals_NNS immunised_VBN with_IN dead_JJ rabies_NNS virus_NN ._.
No_DT ._.
of_IN ex-_JJ periment_NN and_CC animal_JJ im-_NN munised_VBN ._.
Preparation_NN of_IN dead_JJ rabies_NNS virus_VBP used_VBN for_IN immunising_VBG ._.
Time_NNP which_WDT had_VBD elapsed_VBN ._.
after_IN com-_JJ pletion_NN of_IN treatment_NN when_WRB serum_NN was_VBD tested_VBN ._.
Proportion_NN of_IN serum_NN and_CC living_VBG virus_NN tested_VBN ,_, also_RB time_NN and_CC temperature_NN at_IN which_WDT kept_VBD ._.
Test_NNP applied_VBD to_TO mixture_NN of_IN serum_NN and_CC virus_NN ._.
Result_NN ._.
REMARKS_NNP ._.
1_CD ._.
Monkey_NNP ._.
4_CD per_IN cent_NN ._.
rabies_NNS virus_VBP in_IN 0.5_CD per_IN cent_NN ._.
carbo-_JJ lic_JJ acid_NN ._.
11_CD days_NNS Equal_JJ parts_NNS serum_NN and_CC ,_, 1_CD in_IN 300_CD ``_`` fixed_VBN virus_NN ,_, ''_'' kept_VBD 2_CD hours_NNS at_IN 37°C_CD ._.
Rabbit_NNP inocula-_JJ ted_VBD subdurally_RB with_IN 0.2_CD c.c_NNS ._.
Remained_VBN ,_, well_RB ._.
A_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
equal_JJ parts_NNS normal_JJ mon-_JJ key_NN 's_POS serum_NN and_CC 1_CD in_IN 300_CD ``_`` fixed_VBN ,_, virus_NN ,_, ''_'' kept_VBD for_IN 2_CD hours_NNS at_IN 37°C_CD developed_JJ rabies_NNS on_IN the_DT 7th_JJ day_NN ._.
2_CD ._.
Monkey_NNP ._.
Ditto_NNP ._.
11_CD days_NNS Ditto_NNP ditto_NN ._.
Ditto_NNP Rabies_NNP ,_, 10th_CD day_NN ._.
Ditto_NNP ._.
ditto_NN ._.
3_CD ._.
Monkey_NNP ._.
Ditto_NNP 14_CD days_NNS Equal_JJ parts_NNS serum_NN and_CC 1_CD in_IN 200_CD 1st_CD passage_NN human_JJ virus_NN ,_, mixed_JJ and_CC kept_VBD 2_CD hours_NNS at_IN 37°C_CD Ditto_NNP Rabies_NNPS ,_, 17th_CD day_NN ._.
A_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
equal_JJ parts_NNS normal_JJ mon-_JJ key_NN 's_POS serum_NN and_CC 1_CD in_IN 200_CD 1st_CD passage_NN human_JJ virus_NN kept_VBD for_IN 2_CD hours_NNS at_IN 37°C_CD developed_JJ rabies_NNS on_IN the_DT 10th_JJ day_NN ._.
4_CD ._.
Monkey_NNP ._.
Ditto_NNP 14_CD days_NNS Ditto_NNP ditto_NN ._.
Ditto_NNP Remained_NNP well_RB ._.
Ditto_NNP ._.
ditto_NN ._.
5_CD ._.
Dog_NNP Ditto_NNP 11_CD days_NNS Equal_JJ parts_NNS serum_NN and_CC 1_CD in_IN 300_CD ``_`` fixed_VBN virus_NN ``_`` kept_VBD 2_CD hours_NNS at_IN 37°C_CD ._.
Ditto_NNP Ditto_NNP ._.
A_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
equal_JJ parts_NNS normal_JJ dog_NN 's_POS serum_NN and_CC 1_CD in_IN 300_CD ``_`` fixed_VBN virus_NN ``_`` kept_VBD for_IN 2_CD hours_NNS at_IN 37°C_CD developed_JJ rabies_NNS on_IN the_DT 7th_JJ day_NN ._.
.._NN ..._: ._. 23_CD days_NNS Equal_JJ parts_NNS serum_NN and_CC 1_CD in_IN 300_CD 2nd_CD passage_NN jac-_JJ kal_NN 's_POS virus_NN mixed_NN and_CC kept_VBD for_IN 2_CD hours_NNS at_IN 37°C_CD ._.
Ditto_NNP Rabies_NNP ,_, 15th_CD day_NN ._.
A_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
equal_JJ parts_NNS normal_JJ dog_NN 's_POS serum_NN and_CC 1_CD in_IN 300_CD 2nd_CD passage_NN jackal_NN 's_POS virus_NN kept_VBD 2_CD hours_NNS at_IN 37°C_CD developed_JJ rabies_NNS on_IN the_DT 11th_CD day_NN ._.
6_CD ._.
Dog_NNP Ditto_NNP ._.
11_CD days_NNS Equal_JJ parts_NNS serum_NN and_CC 1_CD in_IN 300_CD ``_`` fixed_VBN ,_, virus_IN ``_`` mixed_JJ and_CC kept_VBD for_IN 2_CD hours_NNS at_IN 37°C_CD ._.
Ditto_NNP ._.
Remained_VBN well_RB ._.
A_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
equal_JJ parts_NNS normal_JJ dog_NN 's_POS serum_NN and_CC 1_CD in_IN 300_CD ``_`` fixed_VBN virus_NN ''_'' kept_VBD for_IN 2_CD hours_NNS at_IN 37°C_CD developed_JJ rabies_NNS on_IN the_DT 7th_JJ day_NN ._.
.._NN ..._: ._. 23_CD days_NNS Equal_JJ parts_NNS serum_NN and_CC 1_CD in_IN 300_CD 2nd_CD ._.
passage_NN jac-_JJ kal_NN 's_POS virus_NN ,_, mixed_JJ and_CC kept_VBD 2_CD hours_NNS at_IN 37°C_CD ._.
Ditto_NNP ._.
Rabies_NNS ,_, 15th_CD day_NN ._.
A_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
equal_JJ parts_NNS normal_JJ dog_NN 's_POS serum_NN and_CC 1_CD in_IN 300_CD 2nd_CD passage_NN jackal_NN 's_POS virus_NN ,_, kept_VBD for_IN 2_CD hours_NNS at_IN 37°C_CD developed_JJ rabies_NNS on_IN the_DT 11th_CD day_NN ._.
7_CD ._.
Rabbit_NN ._.
2_CD per_IN cent_NN ._.
virus_NN in_IN 0.5_CD per_IN cent_NN carbolic_NN acid_NN ._.
8_CD days_NNS Equal_JJ parts_NNS serum_NN and_CC 1_CD in_IN 200_CD ``_`` fixed_VBN ,_, virus_NN ,_, ''_'' kept_VBD 2_CD hours_NNS at_IN 37°C_CD ._.
Ditto_NNP ._.
Remained_VBN well_RB A_DT control_NN rabbit_NN inoculated_VBN subdurally_RB with_IN 0.2_CD c.c_NNS ._.
equal_JJ parts_NNS normal_JJ rab-_JJ bit_NN 's_POS serum_NN and_CC 1_CD in_IN 200_CD fixed_JJ ``_`` virus_NN kept_VBD 2_CD hours_NNS at_IN 37°C_CD developed_JJ rabies_NNS on_IN the_DT 7th_JJ day_NN ._.
.._NN ..._: ._. 25_CD days_NNS Ditto_NNP ditto_NN Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
ditto_NN ._.
8_CD ._.
Rabbit_NN ._.
Ditto_NNP ._.
8_CD days_NNS Ditto_NNP ditto_NN Ditto_NNP ._.
Ditto_NNP ._.
Ditto_NNP ._.
ditto_NN ._.
.._NN ..._: ._. 25_CD days_NNS Ditto_NNP ditto_NN Ditto_NNP ._.
Rabies_NNS ,_, 10_CD th_JJ day_NN ._.
Ditto_NNP ._.
Ditto_NNP ._.
All_PDT these_DT experiments_NNS with_IN the_DT serum_NN from_IN immunised_JJ rabbits_NNS ,_, dogs_NNS ,_, and_CC ,_, monkeys_NNS ,_, were_VBD controlled_VBN with_IN serum_NN from_IN normal_JJ rab-_JJ bits_NNS ,_, dogs_NNS ,_, and_CC monkeys_NNS ,_, and_CC treated_VBD exactly_RB the_DT same_JJ after_IN being_VBG mixed_JJ with_IN the_DT same_JJ dilutions_NNS of_IN virus_NN as_IN the_DT serum_NN which_WDT was_VBD being_VBG tested_VBN ._.
All_PDT the_DT control_NN rabbits_VBZ contracted_VBN rabies_NNS after_IN the_DT usual_JJ incubation_NN period_NN according_VBG to_TO the_DT virus_NN used_VBN ._.
29_CD CHAPTER_NN VII_NNP ._.
The_DT advantages_NNS of_IN having_VBG a_DT safe_JJ and_CC efficient_JJ Antirabic_NNP Vaccine_NNP which_WDT could_MD be_VB sent_VBN to_TO wherever_VB it_PRP is_VBZ required_VBN for_IN the_DT treatment_NN of_IN patients_NNS ._.
Antirabic_NNP treatment_NN is_VBZ essentially_RB a_DT prophylactic_JJ treatment_NN ,_, but_CC it_PRP differs_VBZ from_IN the_DT prophylactic_JJ treatment_NN applied_VBN to_TO other_JJ infectious_JJ diseases_NNS in_IN that_DT it_PRP is_VBZ carried_VBN out_IN only_RB when_WRB the_DT patient_NN has_VBZ already_RB been_VBN infected_VBN ,_, and_CC before_IN the_DT infec-_JJ tion_NN has_VBZ had_VBN time_NN to_TO assume_VB an_DT active_JJ phase_NN ._.
On_IN this_DT account_NN it_PRP is_VBZ most_RBS important_JJ when_WRB treatment_NN is_VBZ necessary_JJ ,_, that_IN it_PRP should_MD be_VB commenced_VBN as_RB early_RB as_IN possible_JJ ._.
A_DT person_NN infected_VBN with_IN rabies_NNS virus_NNS can_MD not_RB afford_VB to_TO allow_VB the_DT virus_NN to_TO get_VB a_DT good_JJ start_NN in_IN its_PRP$ growth_NN ,_, and_CC then_RB leisurely_RB to_TO make_VB his_PRP$ way_NN to_TO a_DT Pasteur_NNP Institute_NNP for_IN treatment_NN ._.
In_IN a_DT country_NN like_IN India_NNP where_WRB rabies_NNS is_VBZ so_RB widely_RB spread_NN ,_, and_CC the_DT distances_NNS from_IN a_DT Pasteur_NNP Institute_NNP are_VBP great_JJ ,_, a_DT certain_JJ amount_NN of_IN delay_NN is_VBZ unavoidable_JJ ._.
Those_DT who_WP are_VBP slightly_RB bitten_VBN on_IN the_DT limbs_NNS ,_, or_CC through_IN clothing_NN ,_, can_MD better_VB afford_NN delay_NN than_IN those_DT who_WP are_VBP severely_RB bitten_JJ ,_, or_CC bitten_VB on_IN the_DT head_NN ,_, neck_NN or_CC face_NN ._.
The_DT fact_NN that_IN a_DT large_JJ percentage_NN of_IN persons_NNS bitten_VBN by_IN rabid_NN animals_NNS escape_VBP hydrophobia_RB even_RB without_IN treatment_NN ,_, indicates_VBZ that_IN it_PRP does_VBZ not_RB require_VB a_DT very_RB high_JJ degree_NN of_IN immunity_NN to_TO prevent_VB the_DT virus_NN from_IN multiplying_VBG and_CC giving_VBG rise_NN to_TO hydro-_JJ phobia_NN ._.
Then_RB again_RB ,_, the_DT fact_NN that_IN equally_RB good_JJ results_NNS are_VBP claimed_VBN for_IN any_DT and_CC every_DT method_NN of_IN antirabic_JJ treatment_NN ,_, also_RB indicates_VBZ that_IN a_DT very_RB high_JJ degree_NN of_IN im-_JJ munity_NN is_VBZ not_RB an_DT absolute_JJ necessity_NN in_IN prophylactic_JJ treatment_NN ._.
To_TO my_PRP$ mind_NN the_DT two_CD essential_JJ factors_NNS in_IN any_DT prophylactic_JJ vaccine_NN are_VBP :30_VBN in_IN glass_NN jars_NNS ,_, kept_VBD in_IN a_DT dark_JJ room_NN at_IN a_DT temperature_NN of_IN 22°C_CD the_DT virus_NN has_VBZ lost_VBN all_DT its_PRP$ virulence_NN in_IN 14_CD days_NNS ;_: or_CC in_IN other_JJ words_NNS ,_, it_PRP is_VBZ then_RB a_DT dead_JJ virus_NN ._.
Cords_NNS which_WDT have_VBP been_VBN dried_VBN for_IN a_DT lesser_JJR period_NN than_IN 14_CD days_NNS give_VB very_RB little_JJ evidence_NN of_IN virulence_NN after_IN the_DT 8th_CD or_CC 9th_CD day_NN ,_, and_CC have_VBP not_RB lost_VBN anything_NN in_IN virulence_NN until_IN after_IN the_DT 3rd_CD day_NN ._.
There_EX are_VBP two_CD opinions_NNS as_IN to_TO what_WP happens_VBZ to_TO the_DT virus_NN in_IN the_DT cords_NNS during_IN this_DT drying_VBG process_NN ._.
One_CD opinion_NN is_VBZ ,_, that_IN the_DT virus_NN becomes_VBZ attenuated_VBN ,_, and_CC strictly_RB in_IN accordance_NN with_IN the_DT time_NN the_DT cord_NN has_VBZ been_VBN dried_VBN ;_: and_CC the_DT other_JJ is_VBZ ,_, that_IN the_DT virus_NN is_VBZ only_RB diminished_VBN in_IN amount_NN and_CC not_RB attenuated_VBN ._.
It_PRP is_VBZ a_DT well_RB known_VBN fact_NN that_IN germs_NNS which_WDT can_MD be_VB exalted_VBN in_IN virulence_NN can_MD also_RB be_VB attenuated_VBN in_IN virulence_NN ,_, and_CC that_IN drying_VBG is_VBZ one_CD method_NN of_IN attenuation_NN ._.
It_PRP is_VBZ also_RB accepted_VBN as_IN a_DT fact_NN that_IN rabies_VBZ is_VBZ caused_VBN by_IN a_DT germ_NN of_IN some_DT kind_NN ,_, and_CC a_DT germ_NN which_WDT can_MD be_VB exalted_VBN in_IN virulence_NN ;_: why_WRB then_RB should_MD rabies_VB virus_NN be_VB the_DT exception_NN to_TO a_DT rule_NN which_WDT is_VBZ applicable_JJ to_TO the_DT causal_NN organisms_NNS of_IN other_JJ infectious_JJ diseases_NNS in_IN regard_NN to_TO its_PRP$ attenuation_NN ?_.
As_IN the_DT subject_NN is_VBZ one_CD about_IN which_WDT there_EX are_VBP sure_JJ to_TO be_VB differences_NNS of_IN opinion_NN until_IN it_PRP becomes_VBZ possible_JJ to_TO cultivate_VB the_DT causal_NN organism_NN of_IN rabies_NNS in_IN artificial_JJ media_NNS we_PRP had_VBD better_RBR leave_VB it_PRP with_IN this_DT explanation_NN ;_: moreover_CC ,_, the_DT acceptance_NN of_IN one_CD or_CC other_JJ of_IN these_DT opinions_NNS does_VBZ not_RB materially_RB concern_NN the_DT subject-matter_NN of_IN this_DT paper_NN ._.
Pasteur_NNP commenced_VBD treatment_NN by_IN injecting_VBG vaccines_NNS prepared_VBN from_IN cords_NNS which_WDT had_VBD been_VBN dried_VBN for_IN 14_CD days_NNS ,_, and_CC then_RB from_IN cords_NNS which_WDT had_VBD been_VBN dried_VBN for_IN 13_CD ,_, 12_CD ,_, 11_CD ,_, 10_CD days_NNS ,_, and_CC so_RB on_IN down_RP the_DT scale_NN to_TO cords_NNS which_WDT had_VBD been_VBN dried_VBN for_IN 3_CD days_NNS only_RB ._.
The_DT dose_NN for_IN an_DT adult_NN consists_VBZ of_IN 1_CD c._NN m._NN of_IN cord_NN finely_RB ground_VBD down_RB in_IN 3_CD c.c_NN ._.
of_IN a_DT sterile_JJ fluid_NN ,_, such_JJ as_IN normal_JJ saline_JJ solution_NN ,_, and_CC injected_VBD subcutane-_JJ ously_RB ;_: it_PRP corresponds_VBZ to_TO about_IN a_DT 5_CD per_IN cent_NN ._.
cord_NN emulsion.1_VBZ This_DT method_NN modified_VBN in_IN various_JJ directions_NNS is_VBZ what_WP is_VBZ known_VBN as_IN the_DT ``_`` dried_JJ cord_NN ``_`` method_NN of_IN treatment_NN ._.
It_PRP has_VBZ undergone_RB many_JJ modifications_NNS since_IN Pasteur_NNP 's_POS time_NN ,_, but_CC the_DT system_NN is_VBZ still_RB essentially_RB that_IN of_IN Pasteur_NNP ._.
In_IN the_DT ``_`` dilution_NN method_NN ``_`` of_IN treatment_NN (_( also_RB known_VBN as_IN Högyes_NNP '_POS method_NN )_) the_DT vaccines_NNS are_VBP prepared_JJ direct_JJ from_IN the_DT fresh_JJ cord_NN of_IN a_DT rabbit_NN dead_JJ from_IN ``_`` fixed_VBN virus_NN ``_`` rabies_NNS ._.
It_PRP is_VBZ convenient_JJ to_TO begin_VB by_IN making_VBG a_DT 1_CD per_IN cent_NN ._.
dilution_NN of_IN virus_NN ,_, and_CC from_IN this_DT to_TO prepare_VB any_DT dilution_NN required_VBN ._.
The_DT treatment_NN by_IN this_DT method_NN is_VBZ commenced_VBN by_IN the_DT injection_NN of_IN very_RB weak_JJ dilutions_NNS ,_, such_JJ as_IN 1_CD in_IN 6,000_CD at_IN some_DT Institutes_NNP ,_, and_CC 1_CD in_IN 4,000_CD ,_, or_CC even_RB 1_CD in_IN 2,000_CD in_IN others_NNS ;_: and_CC gradually_RB going_VBG on_IN from_IN day_NN to_TO day_NN to_TO a_DT less_RBR diluted_JJ virus_NN ,_, such_JJ as_IN a_DT 1_CD in_IN 500_CD ;_: 1_CD in_IN 200_CD ;_: or_CC even_RB 1_CD per_IN cent_NN ._.
dilutions_NNS at_IN some_DT Institutes_NNP ._.
1_CD Harvey_NNP and_CC McKendrick31_NNP It_PRP will_MD thus_RB be_VB seen_VBN that_IN in_IN the_DT ``_`` dried_JJ cord_NN ``_`` method_NN ,_, treatment_NN is_VBZ commenced_VBN by_IN a_DT dead_JJ virus_NN ,_, and_CC finally_RB a_DT virulent_NN virus_NN is_VBZ used_VBN ._.
In_IN the_DT ``_`` dilution_NN method_NN ``_`` treatment_NN is_VBZ commenced_VBN by_IN a_DT very_RB small_JJ quantity_NN of_IN a_DT living_NN virulent_NN virus_NN ,_, and_CC increasing_VBG its_PRP$ amount_NN as_IN treatment_NN advances_NNS ._.
Equally_RB good_JJ results_NNS are_VBP claimed_VBN for_IN both_DT methods_NNS and_CC their_PRP$ modifications_NNS ;_: but_CC with_IN these_DT results_NNS I_PRP am_VBP not_RB concerned_VBN in_IN the_DT present_JJ paper_NN which_WDT deals_VBZ solely_RB with_IN the_DT safety_NN and_CC efficiency_NN of_IN a_DT dead_JJ virus_NN ._.
The_DT fact_NN that_IN living_VBG vaccine_NN is_VBZ used_VBN in_IN both_DT methods_NNS would_MD preclude_VB the_DT possibility_NN of_IN sending_VBG it_PRP to_TO a_DT distance_NN for_IN the_DT treatment_NN of_IN patients_NNS without_IN running_VBG serious_JJ risks_NNS of_IN interfering_VBG with_IN its_PRP$ efficiency_NN ;_: whereas_CC a_DT dead_JJ carbolised_JJ vaccine_NN could_MD well_RB be_VB sent_VBN to_TO any_DT centre_NN where_WRB treatment_NN could_MD be_VB carried_VBN out_IN without_IN running_VBG any_DT risks_NNS of_IN injuring_VBG its_PRP$ properties_NNS ._.
The_DT experiments_NNS recorded_VBN in_IN this_DT paper_NN in_IN which_WDT a_DT dead_NN carbolised_VBN rabies_NNS virus_NN was_VBD used_VBN to_TO immunise_VB monkeys_NNS ,_, dogs_NNS and_CC rabbits_NNS ,_, prove_VBP that_IN it_PRP is_VBZ a_DT vaccine_NN which_WDT can_MD be_VB relied_VBN upon_IN to_TO produce_VB a_DT high_JJ degree_NN of_IN immunity_NN ;_: and_CC knowing_VBG that_IN it_PRP is_VBZ a_DT dead_JJ vaccine_NN we_PRP can_MD dismiss_VB any_DT doubts_NNS as_IN to_TO the_DT possibility_NN of_IN its_PRP$ producing_VBG the_DT disease_NN which_WDT it_PRP is_VBZ intended_VBN to_TO prevent_VB ._.
It_PRP is_VBZ also_RB less_RBR expensive_JJ than_IN any_DT other_JJ method_NN ,_, and_CC is_VBZ easily_RB carried_VBN out_RP ._.
A_DT vaccine_NN prepared_VBN from_IN the_DT brain_NN and_CC medulla_NN of_IN ``_`` fixed_JJ virus_NN ``_`` rabbits_NNS would_MD contain_VB more_JJR of_IN the_DT active_JJ element_NN (_( virus_NN )_) than_IN a_DT vaccine_NN prepared_VBN from_IN the_DT spinal_JJ cords_NNS ,_, and_CC on_IN this_DT account_NN its_PRP$ immunising_NN properties_NNS would_MD be_VB greater_JJR than_IN cord_NN vaccine_NN ,_, and_CC moreover_RB the_DT brain_NN and_CC medulla_NN of_IN a_DT rabbit_NN would_MD furnish_VB a_DT much_RB larger_JJR amount_NN of_IN vaccine_NN than_IN the_DT spinal_JJ cord_NN ._.
One_CD Central_NNP Pasteur_NNP Institute_NNP in_IN addition_NN to_TO carrying_VBG out_RP treatment_NN could_MD supply_VB the_DT whole_NN of_IN India_NNP with_IN a_DT vaccine_NN ready_NN to_TO be_VB administered_VBN to_TO patients_NNS at_IN other_JJ centres_NNS ._.
By_IN this_DT means_VBZ patients_NNS would_MD be_VB saved_VBN long_RB and_CC expensive_JJ journeys_NN ;_: and_CC most_RBS important_JJ of_IN all_DT ,_, they_PRP would_MD come_VB under_IN early_JJ treatment_NN ,_, and_CC a_DT treatment_NN free_JJ from_IN risks_NNS ._.
F_NNP 32_CD CHAPTER_NNP VIII_NNP ._.
Summary_NNP of_IN Conclusions_NNP ._.
1_CD ._.
Rabies_NNS virus_NN is_VBZ easily_RB killed_VBN by_IN heat_NN ._.
A_DT temperature_NN of_IN 50°C_CD is_VBZ sufficient_JJ to_TO kill_VB a_DT 5_CD per_IN cent_NN ._.
dilution_NN of_IN ``_`` fixed_JJ virus_NN ``_`` in_IN 15_CD minutes_NNS ._.
2_CD ._.
Rabies_NNS virus_VBP can_MD remain_VB alive_JJ and_CC virulent_NN for_IN several_JJ days_NNS in_IN normal_JJ saline_JJ solution_NN ._.
A_DT ._.
1_CD per_IN cent_NN ._.
dilution_NN of_IN ``_`` fixed_JJ virus_NN ``_`` in_IN normal_JJ saline_JJ solution_NN remains_VBZ alive_JJ and_CC virulent_NN for_IN at_IN least_JJS 15_CD days_NNS at_IN room_NN temperature_NN (_( about_IN 20°C_CD )_) ._.
Dilu-_JJ tions_NNS of_IN 1_CD in_IN 200_CD ,_, and_CC 1_CD in_IN 1,600_CD of_IN ``_`` fixed_JJ virus_NN ``_`` in_IN normal_JJ saline_NN are_VBP not_RB killed_VBN in_IN 24_CD hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD ,_, and_CC not_RB even_RB injured_VBN in_IN any_DT way_NN in_IN 4_CD hours_NNS at_IN this_DT temperature_NN ._.
Dilutions_NNS of_IN 1_CD per_IN cent_NN ._.
rabies_NNS virus_VBP in_IN normal_JJ saline_JJ solution_NN are_VBP not_RB killed_VBN when_WRB kept_NN for_IN 24_CD hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD ,_, then_RB for_IN 24_CD hours_NNS at_IN room_NN temperature_NN ,_, and_CC finally_RB for_IN 24_CD hours_NNS in_IN 0.5_CD per_IN cent_NN carbolic_NN acid_NN at_IN room_NN temperature_NN ._.
3_CD ._.
Rabies_NNS virus_VBP can_MD survive_VB for_IN a_DT longer_JJR time_NN in_IN carbolic_JJ acid_NN at_IN room_NN tempera-_JJ ture_NN (_( about_IN 20°C_CD )_) than_IN at_IN a_DT temperature_NN of_IN 37°C_CD ._.
It_PRP is_VBZ also_RB more_RBR resistant_JJ to_TO carbolic_JJ acid_NN at_IN both_DT these_DT temperatures_NNS than_IN most_JJS non-spore_JJ forming_NN bacteria_NNS ._.
4_CD ._.
A_DT one_CD per_IN cent_NN ._.
dilution_NN of_IN rabies_NNS virus_VBP in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN remains_VBZ alive_JJ and_CC virulent_NN for_IN at_IN least_JJS 20_CD days_NNS at_IN room_NN temperature_NN (_( about_IN 20°C_CD )_) ._.
One_CD per_IN cent_NN ._.
and_CC 2_CD per_IN cent_NN ._.
dilutions_NNS of_IN rabies_NNS virus_VBP in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN remain_VBP alive_JJ and_CC virulent_NN for_IN at_IN least_JJS 4_CD days_NNS at_IN room_NN temperature_NN (_( about_IN 20°C_CD )_) ._.
5_CD ._.
Dilutions_NNS of_IN 4_CD per_IN cent_NN ._.
and_CC 8_CD per_IN cent_NN ._.
rabies_NNS virus_VBP in_IN 1_CD per_IN cent_NN ._.
carbolic_JJ acid_NN normal_JJ saline_JJ solution_NN are_VBP killed_VBN in_IN 24_CD hours_NNS at_IN a_DT temperature_NN of_IN 37°C_CD ._.
Rabies_NNS virus_VBP killed_VBN by_IN this_DT method_NN and_CC then_RB diluted_VBD with_IN an_DT equal_JJ volume_NN of_IN sterile_JJ normal_JJ saline_JJ solution_NN is_VBZ a_DT safe_JJ and_CC efficient_JJ antirabic_JJ vaccine_NN ._.
6_CD ._.
Animals_NNS such_JJ as_IN monkeys_NNS ,_, dogs_NNS ,_, and_CC rabbits_NNS can_MD be_VB highly_RB immunised_VBN by_IN hypodermic_JJ injections_NNS of_IN a_DT rabies_NNS vaccine_NN killed_VBN and_CC preserved_VBN in_IN carbolic_JJ acid_NN ._.
Of_IN 8_CD animals_NNS ,_, viz._NN ,_, 4_CD monkeys_NNS ,_, 2_CD dogs_NNS ,_, and_CC 2_CD rabbits_NNS ,_, immunised_VBN with_IN a_DT 4_CD per_IN cent_NN dead_JJ virus_NN in_IN 0.5_CD per_IN cent_NN ._.
carbolic_JJ acid_NN ,_, all_PDT the_DT monkeys_NNS ,_, one_CD dog_NN ,_, and_CC one_CD rabbit_NN survived_VBD the_DT subdural_JJ inoculation_NN of_IN lethal_JJ doses_NNS of_IN virulent_NN living_NN virus_NN ;_: and_CC the_DT one_CD dog_NN and_CC one_CD rabbit_NN which_WDT did_VBD not_RB survive_VB this_DT test_NN showed_VBD a_DT longer_JJR incubation_NN period_NN than_IN the_DT controls_NNS ._.
7_CD ._.
The_DT serum_NN of_IN animals_NNS immunised_VBN with_IN rabies_NNS vaccine_VBP killed_VBN and_CC preserved_VBN in_IN carbolic_JJ acid_NN gives_VBZ a_DT well_NN marked_VBN rabicidal_JJ action_NN on_IN living_NN virulent_NN virus_NN ._.
8_CD ._.
A_DT rabies_NNS vaccine_NN prepared_VBN from_IN the_DT brain_NN and_CC medulla_NN of_IN ``_`` fixed_JJ virus_NN ``_`` rabbits_NNS ,_, and_CC then_RB killed_VBD and_CC preserved_VBD in_IN carbolic_JJ acid_NN is_VBZ a_DT safe_JJ and_CC efficient_JJ vaccine_NN in_IN the_DT immunisation_NN of_IN animals_NNS ,_, as_IN proved_VBN by_IN experiments_NNS on_IN monkeys_NNS ,_, dogs_NNS ,_, and_CC rabbits_NNS ;_: and_CC judging_VBG from_IN the_DT results_NNS of_IN these_DT experiments_NNS it_PRP should_MD also_RB prove_VB a_DT safe_JJ and_CC efficient_JJ antirabic_JJ vaccine_NN for_IN the_DT prophylactic_JJ treatment_NN of_IN persons_NNS bitten_VBN by_IN rabid_NN animals_NNS ._.
CALCUTTA_NNP SUPERINTENDENT_NNP GOVERNMENT_NNP PRINTING_NNP ,_, INDIA_NNP 8_CD ,_, HASTINGS_NNP STREET_NNP
